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ABSTRACT 
CHARACTERIZING THE MECHANISMS OF  
INSULIN RESISTANCE IN DAIRY CATTLE  
 
Amanda N. Davis 
 
Dairy cows transitioning from gestation to lactation experience insulin resistance as maternal 
adaptation to partition nutrients toward the mammary gland to support milk production. Insulin 
resistance causes increased lipolysis and free fatty acid (FFA) release into circulation. 
Unfortunately, this metabolic adaptation occurs during a time when energy demands are 
heightened and cows are already experiencing negative energy balance. As a result, accelerated 
hepatic FFA influx promotes hepatic triacylglycerol (TAG) accumulation and ketogenesis, which 
can cause postpartum metabolic disease. In diabetic monogastrics, mechanisms that mediate 
insulin resistance involve the sphingolipid ceramide. The role of ceramide in insulin signaling in 
dairy cows transitioning from gestation to lactation has not been previously established. The 
studies presented in this master of science thesis evaluate the relationship between fatty acid 
availability, ceramide synthesis, and insulin sensitivity. In the first experiment, we tested the 
hypothesis that ceramide accumulates in dairy cows experiencing lipolysis and insulin resistance. 
We show that nutrient restriction (NR) increased serum fatty acids and ceramide levels, and 
impaired insulin sensitivity; however, infusion with nicotinic acid (NA), a known suppressor of 
lipolysis, was unable to prevent these responses. We also showed that NR increased hepatic 
ceramide accumulation, a response that was positively associated with serum ceramide supply. 
Our data demonstrate that circulating and hepatic 24:0-Cer are inversely associated with 
systemic insulin tolerance, an effect not observed for the 16:0 moiety. In the second experiment, 
our objective was to characterize relationship between prepartum adiposity and insulin 
sensitivity in dairy cows transitioning from gestation to lactation. Our data demonstrate that 
during the periparturient period, FFA, BHBA, and liver lipid increase, more so for overweight 
cows. While plasma glucose and serum insulin were not affected by adiposity, serum insulin 
concentrations decreased postpartum. Using a hyperinsulinemic-euglycemic clamp (HEC) 
technique to directly measure insulin sensitivity, we show that steady state serum glucose, 
insulin, and FFA levels were not modified by adiposity. HEC glucose infusion rate was not 
affected by adiposity, but systemic insulin resistance developed in overweight cows postpartum 
when accounting for changes in insulin and glucose. Insulin-stimulated phosphorylation of 
subcutaneous adipose tissue AKT was not modified by adiposity, but AKT phosphorylation 
significantly decreased from pre- to postpartum. Collectively, these data demonstrate that 
adiposity does not affect adipose tissue-specific insulin signaling, even though it did impair 
insulin sensitivity as indicated by the SIClamp. 
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Chapter 1 
INTRODUCTION 
 Due to intense genetic selection, milk production per cow has risen dramatically over the 
last century, with cows producing 20,000 kg of milk per lactation (Oltenacu and Broom, 2010). 
This dramatic increase in milk production has been accompanied by a decrease in fertility, an 
increase in the incidence of metabolic disease, and a decrease in longevity of the cow (Oltenacu 
and Broom, 2010). Specifically, these detrimental consequences can be attributed to the 
metabolically challenging transition from gestation to lactation. During the peripartum, the dairy 
cow experiences a coordinated shift in metabolism to divert energy away from maternal 
utilization, and toward the mammary gland to support copious milk production (Bell and 
Bauman, 1997). Unfortunately, the periparturient cow cannot meet the energy demands of 
lactation and in turn the animal relies extensively on catabolism to meet energy requirements 
(Bauman and Currie, 1980).   
 The pancreatic hormone insulin plays a fundamental role in regulating metabolic changes 
that develop during the peripartum. Resistance by peripheral tissues to the insulin signal 
facilitates partitioning of nutrients (e.g., glucose and fatty acids) to the mammary gland to 
support milk synthesis (Hart, 1983). Because insulin is an anti-lipolytic hormone, insulin 
resistance can lead to mobilization of adipose triacylglycerol (TAG) reserves as an adaptation to 
meet energy demand. Moreover, reduction in glucose uptake by skeletal muscle and adipose 
tissue spares glucose for mammary lactose synthesis (Bauman and Currie, 1980; Bell, 1995; Bell 
and Bauman, 1997). The magnitude of insulin resistance may be heightened by adiposity (Zachut 
et al., 2013). Overconditioned cows experience exacerbated lipolysis during the peripartum, 
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which can increase risk of developing a metabolic disease (i.e., fatty liver or ketosis) and 
negatively impact reproductive success.  
Characterizing mechanisms of insulin resistance during energy deficit or in cows with 
enhanced peripartal adiposity is needed to develop practical nutrition and management practices 
to control insulin action and maximize cow health. In diabetic monogastrics with non-alcoholic 
fatty liver disease, mechanisms of insulin resistance involve the sphingolipid ceramide (Holland 
and Summers, 2008). Ceramide represents a lipid mediator that reduces insulin sensitivity in part 
by inhibiting activation of protein kinase B (AKT) within the insulin signaling cascade (Powell 
et al., 2003; Hajduch et al., 2008). Although previous work has demonstrated that hepatic and 
circulating ceramide increases during the transition from gestation to lactation in cows (Rico et 
al., 2015; Rico et al., 2016; Mathews et al., 2016), the effects of energy deficit on ceramide 
accrual remained undefined in dairy cattle; therefore, the hypotheses of these studies were that 
hepatic and circulating ceramide increases in association with controlled feed-restriction and 
insulin antagonism and that prepartum adiposity reduces systemic and localized insulin 
sensitivity via AKT-dependent mechanisms.  
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Chapter 2 
LITERATURE REVIEW 
Energy Metabolism in Dairy Cows 
Dairy cows transitioning from gestation to lactation are challenged by increased energy 
requirements for fetal growth and milk production during a time when energy intake is 
suppressed. Onset of energy deficit begins three weeks prior to parturition, and as parturition 
approaches, maternal dry matter intake (DMI) decreases by 10 to 30% (Bell, 1995). Immediately 
following parturition, net energy for lactation (NEL) and metabolizable protein required for milk 
production exceeds intake by 26 and 25%, respectively (Bell, 1995). Considering that the 
mammary gland uses 97 and 83% of the consumed NEL and metabolizable protein, respectively 
(Bell, 1995), energy deficit can have detrimental consequences on milk synthesis. Because the 
peripartal cow experiences high nutrient demand, a physiological state of negative energy 
balance (NEB) develops. To meet the heightened demand for energy, the cow will mobilize 
energy stores including triacylglycerol (TAG), protein, and glycogen. As lactation advances, 
intake is restored, energy balance improves, and energy stores are repleted. 
The onset of lactation is characterized by homeorhetic adaptations that facilitate the 
partitioning of nutrients away from maternal utilization and toward the mammary gland for milk 
component synthesis. First, the mammary gland uses glucose for synthesis of lactose, the major 
osmotic regulator of milk volume. To ensure adequate glucose delivery to the mammary gland, 
hepatic gluconeogenesis increases (Reynolds et al., 2003) and oxidation of glucose by peripheral 
tissues decreases (Bennink et al., 1972). Substrates for gluconeogenesis include propionate from 
microbial fermentation in the rumen, lactate from the Cori cycle, amino acids (AA; e.g. alanine) 
from protein catabolism, and glycerol mobilized from adipose tissue TAG (Seal and Reynolds, 
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1993). The cow relies predominantly on propionate as a substrate for gluconeogenesis; however 
the contribution from glycerol increases during energy deficit and associated adipose tissue 
mobilization (Lomax et al., 1983; Aschenbach et al., 2010). Furthermore, peripartal glucose 
uptake by skeletal muscle and adipose tissue is decreased because of the development of 
localized insulin resistance, thereby facilitating glucose uptake by the mammary gland in an 
insulin-independent manner (Bell and Bauman, 1997; De Koster and Opsomer, 2013). 
Development of insulin resistance also partitions free fatty acids (FFA) to the mammary gland 
for their re-esterification into milk fat TAG. (McNamara and Hillers, 1986; Zachut et al., 2013). 
Noticeable increases in milk fat yields and content are observed immediately postpartum, 
relative to mid or late lactation. Additionally, circulating FFA are used for β-oxidation in 
peripheral tissues and hepatic ketogenesis. Beyond peak milk production, insulin sensitivity in 
peripheral tissues is restored to partition glucose toward skeletal muscle and adipose tissue, and 
away from the mammary gland (McNamara and Hillers, 1986; Bell and Bauman, 1997). As a 
consequence, nutrients are diverted towards body tissue accretion and the developing fetus as 
positive energy balance is reestablished.  
Metabolic Disease 
In dairy cows, negative energy balance can promote the development of metabolic 
disease during the peripartum. A hallmark characteristic of metabolic impairment is 
accumulation of fat in liver tissue (i.e., fatty liver disease). Although FFA can be oxidized in 
liver, fatty liver develops because of increased FFA esterification in response to elevated FFA 
uptake (Pullen et al., 1989; Reynolds et al., 2003). Moreover, hepatic TAG export within very 
low density lipoprotein (VLDL) is much lower in ruminants compared to nonruminants (Pullen 
et al., 1990). Therefore, when the rate of hepatic FFA influx exceeds the rate of oxidation and 
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export during the peripartum, liver lipid accumulation ensues (Hocquette and Bauchart, 1999). 
The low secretion of VLDL from the liver may be due to limited availability of VLDL 
components (Bauchart et al., 1996). Such components may include apolipoproteins, cholesterol, 
or phosphatidylcholines (Bernabucci et al., 2004; Loor et al., 2007; Kessler et al., 2014). 
In addition to hepatic TAG accumulation, excessive oxidation of fatty acids can 
contribute to rampant ketogenesis (i.e., the production of acetoacetate, acetone, and β-
hydroxybutyrate (BHBA) from acetyl-CoA). In turn, elevated levels of ketones promote clinical 
and subclinical ketosis (Esposito et al., 2014). Furthermore, fatty liver disease can interfere with 
hepatic gluconeogenesis by limiting transformation of propionate to glucose in part by inhibiting 
the vitamin B12-dependent enzyme methylmalonyl-coA mutase (Piepenbrink and Overton, 
2003b; McDowell, 2000; Preynat et al., 2010). Fatty liver disease and ketosis are linked with 
immunosuppression, which is likely a cause of retained placenta (Ingvartsen et al., 2003) and 
environmental mastitis (Mallard et al., 1998). Moreover, cows that experience retained placenta 
often develop metritis and become infertile (Coleman et al., 1985). Other disorders associated 
with NEB and poor hepatic health include displacement of the abomasum, metritis, and milk 
fever (Le Blanc et al., 2005a, b). Collectively, the onset of these metabolic diseases can 
compromise milk production and fertility that can result in enhanced veterinary costs and culling 
rates (Wathes et al., 2007). Therefore, novel nutritional strategies are needed to improve bovine 
energy status and hepatic health during the peripartum.  
Dietary approaches to mitigate disease 
Pregnant cows fed in nutrient excess are susceptible to body fat accumulation (Morrow, 
1976; Roche et al., 2013), which can cause a more severe decrease in DMI around calving 
thereby contributing to excessive adipose tissue lipolysis (Rico et al., 2015; Holtenius et al., 
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2003; Holtenius et al., 2007). Lean cows [body condition score (BCS) of 2-2.5; Wildman et al., 
1982] tend to have higher DMI and milk yield postpartum than cows with excessive adiposity 
(BCS of 3.5 to 4; Garnsworthy and Topps 1982a, 1982b; Treacher et al., 1986; Garnsworthy and 
Jones, 1987). Moreover, an elevated calving and early lactation BCS are associated with an 
increased incidence of ketosis (Gillund et al., 2001), milk fever (Roche and Berry, 2006), and 
fatty liver (Drackley, 1999). Cows that exhibit a greater BCS loss during the early postpartum (≥ 
1.25 points) are half as likely to conceive at first insemination and thus have a longer calving to 
conception interval (Gillund et al., 2001). Considering this evidence, dairy producers are 
encouraged to manage cattle to achieve a BCS of 3.0 to 3.25 at dry off (~40 to 60 d prepartum; 
Contreras et al., 2004; Gillund et al., 2001).  
Controlling prepartum adiposity can be achieved by limiting dietary energy intake. 
Douglas and colleagues (2006) fed moderate grain- or fat-supplemented diets (1.50 Mcal of 
NEL/kg) from dry off (60 days before expected parturition) to calving at either ad libitum (160% 
of NEL requirement) or restricted (80% of NEL requirement) intakes. During the first 21 days in 
milk, cows previously energy-restricted had higher intakes of DMI and NEL. Relative to ad 
libitum feeding, nutrient restriction reduced plasma concentrations of FFA and BHBA, and liver 
concentrations of total lipid and TAG postpartum. In support of this work, Dann and coworkers 
(2006) found similar metabolite responses postpartum when comparing a high plane (150% of 
NRC energy requirements) versus a low plane of nutrition (80 or 100% or NRC requirements) 
during the early dry period (from dry-off to -25 d relative to expected parturition). Interestingly, 
plane of nutrition during the close-up period (three weeks prepartum) did not affect these 
parameters postpartum (Dann et al., 2006). Moreover, Mann and coworkers (2015) examined the 
effects of feeding a high fiber, controlled-energy diet for the dry period duration (100% of 
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energy requirements; starting 57 days before expected parturition) versus a high-non-fiber 
carbohydrate (NFC), high-energy- diet (150% of energy requirements). A third treatment group 
received the high energy diet for the first 28 days after dry off followed by an intermediate diet 
containing 125% of energy requirements until calving. They found that cows fed a high plane of 
nutrition had higher circulating BHBA and FFA, and more severe NEB postpartum. The 
controlled-energy diet improved energy balance as well as lowered the frequency and severity of 
hyperketonemia postpartum. More so, switching from a high-energy diet to an intermediate-
energy diet during the close-up period did not completely ameliorate negative effects of feeding 
a high-energy diet for the duration of the dry period. 
Although restricting energy for the entire dry period appears to benefit cow health and 
milk production, some evidence supports feeding a higher energy diet for two to three weeks 
before calving (Mashek and Beede, 2001; Corbett, 2002; Contreras et al., 2004), a response that 
is likely due to the source of dietary carbohydrate (CHO) fed. Specifically, the concentration of 
non-fiber CHO (NFC; e.g., highly digestible sugars and starch) and neutral detergent fiber (NDF; 
e.g., cellulose, hemicellulose, and lignin) can influence microbial fermentation and volatile fatty 
acid production. Volatile fatty acids (e.g., propionate, butyrate, and acetate) are essential energy 
sources derived from rumen microbial fermentation of CHO (Bergman, 1990; Nafikov and Beitz, 
2007). Undoubtedly, energy density of the postpartum diet must be increased to meet the demand 
of lactation. However, a sudden increase in dietary energy density from highly fermentable NFC 
may lead to subacute ruminal acidosis due to lactate accumulation, which can decrease DMI, 
contribute to NEB and thus FFA mobilization and hepatic lipid deposition (Ingvartsen et al., 
2006; Mulligan and Doherty, 2008). Using close-up diets containing increased levels of starch 
has been suggested to allow the rumen to adapt to a high-grain diet before the onset of lactation. 
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A number of studies have reported positive effects on metabolism postpartum after feeding a 
higher concentration of NFC prepartum (reviewed by Overton and Waldron, 2004). For example, 
Minor and coworkers (1998) found that cows fed a high NFC diet for 19 days before calving had 
higher plasma glucose concentrations and lower FFA and BHBA concentrations, reduced liver 
lipid accumulation, and higher milk production than cows fed a low NFC diet. However, it is 
difficult to attribute changes in metabolic health postpartum to dietary CHO source prepartum 
because most experiments examining the effects of NFC content of the prepartum diet have 
confounding effects due to either energy content (Minor et al., 1998; Mashek and Beede, 2000; 
Holcomb et al., 2001) or fat content (Grum et al., 1996). Smith and coworkers (2005, 2008) 
examined the effects of NFC content in prepartum diets independent of dietary energy or fat 
content. They offered cows one of two diets from day -21 relative to parturition until calving 
containing either high NFC (40.3% of dry matter) or low NFC (33.6% of dry matter). Milk yield 
and dry matter intake were not affected by prepartum NFC source (Smith et al., 2005). Cows fed 
the high NFC diet tended to have lower plasma FFA concentrations postpartum. However, cows 
on this diet also tended to have higher BHBA and lower liver glycogen concentrations (Smith et 
al., 2008) making interpretation challenging. Collectively, feeding high-energy diets for the 
entirety of the dry period has negative effects on health and milk production, and feeding a low 
plane of nutrition for the dry period duration is recommended to minimize the incidence of 
postpartum metabolic disease; however, more research is needed to determine the balance of 
NFC and energy necessary during the closeup period to improve metabolic health during the 
early postpartum. 
Dietary fats may also affect metabolism and reproduction during the peripartum, and fat 
supplementation represents a common practice on dairy farms. Feeding fat supplements that can 
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suppress milk fat production during the early postpartum period may help to minimize NEB, 
reduce adipose tissue mobilization, and improve fertility. For example, Caldari-Torres and 
colleagues (2011) examined the effects of feeding diets enriched in either saturated fatty acids 
(SFA), calcium (Ca) salts of trans-octadecenoic fatty acids (tFA), or Ca salts of safflower oil 
fatty acids (SFL) starting 28 days before expected parturition on performance, metabolic, and 
endocrine responses. Cows fed SFL produced less milk fat and entered positive energy balance 
sooner after parturition than those fed tFA. Furthermore, plasma FFA concentrations were lower 
in cows fed the SFL diet than in those consuming the tFA diet. Moreover, plasma glucose, 
insulin-like growth factor-I (IGF-I), and progesterone were greater in animals fed the SFL-
enriched diet compared with those fed SFA, reflecting improved energy balance and potential 
corpus luteum development. Altering the ratio of dietary n-6 to n-3 fatty acids (FA) during the 
peripartum can influence the release of prostaglandin F2α (PGF2α), an eicosanoid that controls 
the lifespan of the corpus luteum and might influence the retention of fetal membranes (Santos et 
al., 2008). Petit and coworkers (2004) showed that feeding n-6 FA resulted in increased 
circulating PGF2α following an oxytocin challenge early postpartum (Petit et al., 2004), while 
feeding n-3 FA has been shown to reduce PGF2α production after an oestradiol/oxytocin 
challenge (Mattos et al., 2002). Furthermore, Silvestre and colleagues (2011) examined the effect 
of feeding Ca-salts of palm oil (PO; low in n-6 and n-3 FA) or safflower oil (SO; high in n-6 FA) 
from 30 days prepartum to 30 days postpartum, followed by feeding Ca-salts of PO or fish oil 
(high in n-3 FA) from 30 to 160 days postpartum. They found that supplementation of n-3 FA 
decreased pregnancy loss from the first artificial insemination and increased second service 
pregnancy per service. This effect was enhanced when cows were fed n-6-enriched diets during 
the transition period. The combination of feeding n-6 FA during the transition period followed 
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by feeding n-3 FA during the breeding period represented the best combination of FA 
supplementation. Silvestre and coworkers (2011) suggested that n-3 FA increases the 
concentrations of eicosapentaenoic and docosahexaenoic acids in the caruncular and endometrial 
tissues, which competitively inhibit arachidonic acid from producing PGF2α , thus delaying 
luteolysis (Mattos et al., 2000; 2003; 2004).  
Collectively, current research supports that to maintain postpartum metabolic health and 
milk production restriction of energy intake during the dry period is recommended to promote 
DMI and improve energy balance after calving. However, the short-term application of a 
moderate-starch diet immediately before expected calving can prepare the rumen for high energy 
early lactation diets. Finally, feeding polyunsaturated fatty acids during the postpartum may 
represent a method to improve metabolic health if compromised by energy impairments caused 
by prepartum overnutrition. 
Insulin Sensitivity in Dairy Cows  
Insulin signaling cascade 
The insulin signaling transduction pathway has been extensively studied in monogastrics 
(Chavez and Summers, 2010). In the fed state, insulin stimulates uptake of glucose into insulin-
sensitive adipose and skeletal muscle tissues, and inhibits lipolysis (Duncan et al., 2007). The 
cascade of events begins with insulin binding to its receptor. The insulin receptor consists of two 
α-subunits and two β-subunits linked by disulfide bonds. The α-subunits are extracellular and 
contain an insulin binding site, while the cytosolic β-subunits are adjacent to the plasma 
membrane (Hedo and Simpson, 1984). When insulin binds to the α-subunit, the β-subunits 
become activated by auto-phosphorylation of tyrosine residues (Kasuga et al., 1982; Ward and 
Lawrence, 2009). The β-subunit then recruits the insulin receptor substrate (IRS) protein and 
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uses its tyrosine kinase activity to phosphorylate IRS on multiple tyrosine residues. 
Phosphorylation of IRS signals for the recruitment and activation of phosphatidylinositol 3-
kinase (PI3K; Sun et al., 1993; Avruch, 1998). Phosphatidylinositol 3-kinase contains Src-
homology-2 domains that bind to tyrosine-phosphorylated IRS, which then activates the catalytic 
subunit of PI3K (Myers et al., 1992; Virkamäki et al., 1999; Shaw, 2011). Activation of PI3K 
signals recruitment and phosphorylation of phosphatidylinositol 4,5-bisphosphate (PIP2) to form 
phosphatidylinositol 3,4,5-triphosphate (PIP3) at the plasma membrane. These phosphoinositides 
then recruit protein kinase B (AKT) to the plasma membrane, where it becomes phosphorylated 
on specific threonine and serine residues by phosphoinositide-dependent kinase-1 (PDK-1) and 
PDK-2, respectively (Saltiel and Kahn, 2001; Petersen and Shulman, 2006).  
Protein kinase B can then mediate activation of lipogenesis, glycogen synthesis, and 
glucose uptake via translocation of the only insulin sensitive glucose transporter, GLUT4, to the 
plasma membrane (Bae et al., 2003), and inhibit gluconeogenesis and glycogenolysis through 
activation of glycogen synthase kinase-3 (Cross et al., 1995), AKT substrate 160 (Karlsson et al., 
2005), and forkhead box protein 01 (Tzivion et al., 2011). Insulin’s anti-lipolytic effect is also 
mediated by AKT. Specifically, insulin signaling activates phosphodiesterase 3B (PDE3B) via 
AKT-mediated phosphorylation of serine residue 273 (Degerman et al., 1998; Kitamura et al., 
1999). When PDE3B is activated, it catalyzes hydrolysis of cyclic adenosine monophosphate 
(cAMP) to 5’AMP so that protein kinase A (PKA) activity is reduced (Manganiello et al., 1996; 
Degerman et al., 1997). Reduction in PKA leads to decreased activity of hormone-sensitive 
lipase and reduction in TAG hydrolysis (Eriksson et al., 1995; Beebe et al., 1985; Degerman et 
al., 1990).  
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Mechanisms of insulin resistance 
Besides insulin, other endocrine hormones such as glucagon, epinephrine, and GH play a 
role in coordinating the anabolic to catabolic shift in metabolism that accompanies the transition 
from gestation to lactation. First an increase in gluconeogenesis during lactation is promoted by 
glucagon and catecholamines. Glucagon enhances the supply of gluconeogenic precursors by 
mobilizing FFA and glycerol from adipose tissue, and catecholamines stimulate lactate 
production from muscle (Hart et al., 1983). Moreover, somatotropin (growth hormone, GH) is a 
known to inhibit insulin-stimulated glucose uptake and lipogenesis in adipose tissue (Bauman 
and Vernon, 1993). Under normal conditions, GH increases circulating concentrations of insulin-
like growth factor I (IGF-I), which inhibits further production of GH by the pituitary gland 
(Bichell et al., 1992; Le Roith et al., 2001). The GH-IGF-I axis uncouples in the liver during high 
nutrient demand, as during the transition to lactation (Thissen et al., 1994), resulting in decreased 
IGF-I and increased GH in circulation (Taylor, 2004). Therefore, researchers hypothesized that 
GH is responsible for causing insulin resistance during early lactation (Bell and Bauman, 1997). 
This hypothesis was supported by the observation that chronic treatment of lactating dairy cows 
with bovine somatotropin (bST) decreased insulin-dependent GLUT4 mRNA expression in 
omental adipose tissue (Zhao et al., 1996). Moreover, bST administration reduced insulin 
receptor concentration and tyrosine kinase activity in skeletal muscle of rapidly growing lambs 
(Wilson et al., 1996), and lowered GLUT4 mRNA expression in lactating dairy cow muscle 
(Zhao et al., 1996). This hypothesis was further strengthened by the observation that bST 
administration had no effect on the abundance of GLUT1 mRNA, which is not insulin-
responsive, in the mammary gland of lactating cows (Zhao et al., 1996). 
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 The transition from gestation to lactation is characterized by a dynamic change in 
metabolic regulation to support fetal growth and milk synthesis, and insulin certainly plays a 
major role to facilitate glucose partitioning towards the fetus and the mammary gland (Bauman 
Currie, 1980). The concentration and sensitivity to insulin decreases dramatically as lactation 
approaches (Bauman and Currie, 1980; Bell, 1995; Bell and Bauman, 1997). A decrease in 
circulating insulin concentration in part reduces insulin-stimulated glucose uptake. Also, the 
decrease in circulating insulin concentration is accompanied by a decrease in insulin sensitivity 
(i.e., increased insulin resistance) as a metabolic adaptation to lactation (Bell and Bauman, 1997; 
Kerestes et al., 2009). A reduction in insulin sensitivity increases hepatic gluconeogenesis and 
lipolysis to meet the demands of milk production. Moreover, the relationship between NEB and 
systemic insulin sensitivity is well established. For example, partial nutrient restriction or fasting 
decreases insulin-stimulated glucose clearance measured with an insulin tolerance test (ITT; 
Oikawa and Oetzel, 2006) or glucose tolerance test (GTT; Pires et al., 2007; Schoenberg et al., 
2012), and insulin responsiveness is negatively correlated with circulating FFA (Oikawa and 
Oetzel, 2006). Furthermore, inducing hyperlipidemia in dairy cows by intravenous infusion of 
tallow emulsion can impair glucose clearance during a GTT or ITT, reflecting lower 
responsiveness to insulin during elevated hepatic FA influx (Pires et al., 2007a).  
In monogastrics, molecular mechanisms of FFA-mediated insulin resistance are well-
established. For example, administering saturated FFA to muscle cells decreases phosphorylation 
(i.e., activation) of AKT (Chavez et al., 2003). Additionally, elevation in FFA can result in serine 
(rather than tyrosine) phosphorylation of IRS-1, leading to disruption of downstream 
phosphorylation and insulin signal transduction (Le Marchand-Brustel et al., 2003). Also, protein 
kinase C-ζ activation serves as a negative regulator for AKT (Konishi et al., 1994; Doornbos et 
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al., 1999). While changes in systemic insulin sensitivity during the peripartum is well established 
in dairy cows, molecular mechanisms contributing to insulin resistance in cows experiencing 
overnutrition are not well understood. It has been proposed that peripheral-tissue specific insulin 
resistance develops postpartum in cows prone to high weight loss, as evidenced by lack of 
phosphorylation of AKT in adipose tissue postpartum compared to prepartum (Zachut et al., 
2013). However, recent evidence confounds this hypothesis. For example, Mann and colleagues 
(2016) measured phosphorylation of AKT and hormone sensitive lipase (HSL) in adipose tissue 
of cows overfed by 50% of requirements in the dry period compared to controls, and detected no 
differences between groups. This can potentially be explained by the fact that the high energy 
diet did not cause a significant increase in BCS compared to controls. They did observe 
phosphorylation of HSL is increased postpartum, which is supported by the work of Locher and 
coworkers (2011). They suggest the reason for an increase in circulating FFA postpartum in 
cows overfed prepartum is not due to changes in adipose tissue insulin signaling, but rather due 
to lower circulating concentrations of glucose and insulin postpartum contributing to greater 
negative energy balance, and due to an increase in total amount of mobilized adipose tissue mass 
(Mann et al., 2016).  
Potential role of ceramide as a mediator of insulin resistance 
In overweight, type 2 diabetic monogastrics, the antagonistic effects of FFA on insulin 
sensitivity are mediated in part by the sphingolipid ceramide (Holland and Summers, 2008). 
Ceramides were previously described as merely structural elements of cell membranes; however, 
recent research implicates ceramides as bioactive lipid mediators that play a role in a number of 
cellular processes including cell cycle arrest, apoptosis, and stress responses (Hannun, 1996). 
Ceramide synthesis involves three different pathways including de novo synthesis, 
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sphingomyelin hydrolysis, and the salvage pathway. Distinct activation of these pathways may 
be possible due to compartmentalization of enzymes that contribute to ceramide formation 
(Kitatani et al., 2008). First, ceramides can be generated de novo by condensation of palmitoyl-
coA and serine in a reaction catalyzed by serine palmitoyl transferase (SPT) to form 3-
ketosphinganine (Merrill and Wang, 1986). The keto group is then reduced using 3-
ketodihydrosphingosine reductase to form sphinganine (Merrill and Wang, 1986; Perry 2002; 
Menaldino et al., 2003). Dihydroceramide synthase then adds an acyl group, forming a 
dihydroceramide (Merrill and Wang, 1986; Perry 2002; Menaldino et al., 2003). Different 
dihydroceramide synthase isoforms exist to produce specific ceramides with unique carbon chain 
length, which accounts for their diversity (Mizutani et al., 2005; Lahiri et al., 2005; Park and 
Pewzner-Jung, 2013). Dihydroceramide desaturase then converts dihydroceramide to ceramide, 
which contains a 4, 5-trans-double bond in the sphingosine group (Merrill and Wang, 1986; 
Rother et al., 1992, Perry 2002; Menaldino et al., 2003). Following synthesis, ceramide can be 
glycoslyated to form glucosylceramide, lactosylceramide, and gangliosides (Reynolds et al., 
2004). Second, ceramides can also originate from sphingomyelin hydrolysis mediated by 
sphingomyelinases (SMases) classified as acid-, alkaline-, or neutral-SMase based on their 
optimal pH (Callahan et al., 1983; Nilsson, 1969; Wu et al. 2010). Third, the salvage pathway 
involves use of several enzymes including SMases, glucocerebrosidase, ceramidases, and 
(dihydro) ceramide synthases to breakdown complex sphingolipids into sphingosine and 
regenerate ceramide (Riboni et al., 1997; Kitatani et al., 2008). Researchers estimate that 50-90% 
of sphingolipid biosynthesis comes from recycling of long chain-sphingoid bases (Gillard et al., 
1998; Tettamanti et al., 2003), which suggests perhaps sphingolipid breakdown plays an 
important role in ceramide biosynthesis and signal transduction (Kitatani et al., 2008). 
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In obese humans with type 2 diabetes, the severity of insulin resistance is correlated with 
circulating 18:0-, 20:0-, 24:1-, 24:0- and total ceramide (Cer; Haus et al., 2009). Moreover, the 
ability of the liver to de novo synthesize ceramide due to an oversupply of FFA has been 
previously established in humans and rats (Holland et al., 2007; Watt et al., 2012). Specifically, 
an elevation in SFA (e.g., palmitate) contributes to ceramide production through condensation 
with SPT in the first step of de novo ceramide synthesis. Ceramide blocks normal insulin 
signaling by recruiting protein kinase C-ζ and inactivating AKT (Powell et al., 2003; Hajduch et 
al., 2008). Phosphodiesterase 3B is inactivated as a result, leading to accumulation of cAMP and 
enhanced lipolysis (Mei et al., 2002; Holm 2003). Thus, ceramide appears to work in a vicious 
cycle whereby NEB leads to mobilization of FFA, elevated FFA concentration leads to ceramide 
formation, and ceramide accrual further activates lipolysis potentially leading to non-alcoholic 
fatty liver disease and other metabolic disorders in humans. However, these mechanisms 
remained to be confirmed in ruminants. 
Ceramide’s ability to antagonize insulin action may be a function of its acyl moiety 
(Boon et al., 2013, Raichur et al., 2014; Turpin et al., 2014).  Controversy exists about the role of 
16:0- vs. 24:0-Cer on insulin resistance (Raichur et al., 2014; Turpin et al., 2014). The most 
abundant ceramide in human circulation is 24:0-Cer, which has been identified in association 
with type 2 diabetes (Haus et al., 2009). Increases in LDL containing either 16:0- or 24:0-Cer 
decreases systemic and skeletal muscle glucose uptake in lean mice by inhibiting insulin-
stimulated AKT phosphorylation (Boon et al., 2013). In contrast, when a high fat diet was 
administered to ceramide synthase-2 knockout mice displaying lower hepatic 24:0-Cer, 16:0-Cer 
was increased through overexpression of ceramide synthase 6, and insulin sensitivity was 
hindered. Similarly, Turpin and coworkers (2014) found that in adipose tissue of obese humans, 
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ceramide synthase 6 gene expression is increased causing an elevation in 16:0-Cer and insulin 
resistance. However, Meikle and colleagues (2013) found that 16:0-Cer and type 2 diabetes are 
not related. Therefore, the effect of 16:0- and 24:0-Cer on insulin sensitivity may be due to either 
intracellular or extracellular compartmentalization of ceramide; however, future research is 
required. 
We have recently demonstrated that greater adiposity is associated with a more extreme 
loss in body condition during the peripartum and that overweight cows (increased BCS) have 
elevated plasma glucose, insulin, FFA, and lower estimated insulin sensitivity compared to their 
lean counterparts (Rico et al., 2015). Additionally, circulating ceramides are elevated in dairy 
cows during the transition period, are positively correlated with FFA, and are negatively 
correlated with insulin sensitivity (Rico et al., 2015; Rico et al., 2016; Mathews et al., 2016). 
Moreover, supplementing cows with palmitatic acid during mid-lactation increases hepatic 
synthesis and plasma accumulation of ceramide, decreases insulin sensitivity, and improves milk 
production (Rico et al., 2016); thus demonstrating that ceramide may be able to restore insulin 
resistance during positive energy balance via ceramide-dependent mechanisms. 
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Chapter 3 
NUTRIENT RESTRICTION INCREASES CIRCULATING AND HEPATIC 
CERAMIDE IN DAIRY COWS DISPLAYING IMPAIRED INSULIN TOLERANCE 
Introduction 
Development of insulin resistance in dairy cattle represents a homeorhetic adaptation to 
support milk production (Bell, 1995). Specifically, reduced insulin sensitivity in adipose and 
skeletal muscle tissue develops during early lactation as a means to partition glucose to the 
mammary gland (Bell, 1995). Increased energy requirements for lactation coupled with 
suppressed energy intake promotes accelerated adipose tissue lipolysis and hepatic lipid 
deposition during the peripartum which represent unfavorable conditions that promote metabolic 
disease when uncontrolled (e.g., fatty liver and ketosis). As lactation advances beyond peak milk 
production, insulin sensitivity and metabolic health improves as positive energy balance is 
restored (Bell, 1995; McNamara and Hillers, 1986). Characterization of the mechanisms that 
regulate insulin action in dairy cows is necessary to identify approaches to improve cow health 
and lifelong milk production.  
 The sphingolipid ceramide mediates the pathophysiology of insulin resistance in diabetic 
monogastrics (Holland et al., 2007; Chavez and Summers, 2012). Membrane ceramide inhibits 
insulin signaling by recruiting protein kinase C-ζ and inactivating AKT (Powell et al., 2003; 
Hajduch et al., 2008). As a consequence, PDE3B is inactivated, cAMP accumulates, and the 
lipolytic release of FFA is enhanced (Mei et al., 2002; Holm, 2003). We have recently 
established that circulating ceramide (e.g., 24:0-Cer) is elevated in dairy cows transitioning from 
gestation to lactation (Rico et al., 2015), and lactating cows fed supplemental palmitic acid (Rico 
et al., 2016). Moreover, we demonstrated that circulating ceramide is positively related to FFA 
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supply and inversely associated with insulin sensitivity (Rico et al., 2015; Rico et al., 2016; 
Mathews et al., 2016). The central hypothesis of this manuscript is that ceramide may represent a 
maternal adaptation to support nutrient partitioning and milk production in dairy cattle.  
 Considering that the relationship between dietary energy intake and ceramide supply has 
not been investigated in dairy cattle, our objective was to evaluate changes in circulating and 
hepatic ceramide levels during controlled feed restriction. To assess ceramide responses, a feed 
restriction protocol was employed to promote lipolysis and insulin resistance, and ceramide 
levels were quantified using mass spectrometry. The effects of nicotinic acid (NA), a known 
suppressor of lipolysis (Pires et al., 2007; Pires and Grummer 2007b), was also assessed, 
although we recognized that chronic NA treatment can antagonize insulin action (Heemskerk et 
al., 2014; Pires et al., 2016). Herein, it was confirmed that feed restriction increases circulating 
and hepatic ceramide; however, NA treatment was unable to prevent ceramide accrual or 
improve insulin sensitivity. In support of our previous work, these data revealed that circulating 
and hepatic 24:0-Cer are inversely associated with insulin sensitivity. 
Materials and Methods 
Experimental Design  
Experimental procedures were approved by the West Virginia University Institutional 
Animal Care and Use Committee (Morgantown) and were completed at the West Virginia 
University Animal Science Farm. Nine non-lactating, non-pregnant Holstein cows (2.6 ± 0.9 
parity; 617 ± 51 kg body weight (BW); 3.0 ± 0.3 body condition score (Wildman et al., 1982) 
were housed in a free stall barn and trained to access feed by using Calan gate feeders (American 
Calan Inc., Norwood, NH). Cows were enrolled 14 d before treatment and randomly allocated to 
1 of 3 groups in a replicated 3×3 Latin square design. Cows were ad libitum fed, nutrient-
restricted (NR), or NR with nicotinic acid (NA; 5 mg of NA/h per kg BW; delivered i.v.) for 34 
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h. When provided access, cows were ad libitum fed (0800 and 1800 h) a mixed ration of grass 
hay and ground corn to meet or exceed requirements (Table 3.1) (NRC, 2001). Nutrient-
restricted cows were provided with vitamins and minerals that were mixed with wheat middlings 
as a carrier (1 kg/d) to meet requirements (NRC, 2001). Nicotinic acid (99% purity; Vetagro 
S.p.A., Reggio Emilia, Italy) was administered to suppress lipolysis, and prepared with 
equimolar amounts of sodium bicarbonate to facilitate solubilization in saline in accordance with 
previously established methods (Pires et al., 2007b). Post-treatment, all cows were provided ad 
libitum access to feed and monitored for an additional 8 h. Two 14-d recovery periods were 
included. Because fluctuations in circulating progesterone may influence insulin sensitivity 
(Livingstone and Mary, 2002), an intravaginal progesterone-releasing device (1.38 g; Eazi-Breed 
CIDR; Zoetis Inc., Florham Park, NJ) was inserted and replaced every 7 d throughout 
experimentation. Free access to water was ensured at all times. Body weights and body condition 
scores were recorded within 36 h of the initiation of treatment. 
Sampling Procedures 
Following established procedures (Mathews et al., 2016; Pires and Grummer, 2007a), 
cows were fitted with two indwelling jugular catheters (Micro-Renathane implantation tubing; 
Braintree Scientific, Inc., Braintree, MA) into each jugular vein 36 h prior to the initiation of 
treatments. Patency was maintained by flushing with heparinized saline every 12 h when not in 
use. Blood (8 mL) was collected at -48 (0700 h), -24, 0, and every 2 h until h 34, relative to the 
start of treatment. Post-treatment, blood was collected at 1, 2, 4, 6, and 8 h (35, 36, 38, 40, and 
42 h relative to the start of treatment, respectively). Blood samples were transferred into a glass 
test tube and serum was harvested following centrifugation (3,400 × g for 10 min at 4°C), frozen 
on dry ice, and stored at -80°C until analyzed.  
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Liver biopsies were performed at h 32 relative to the start of treatment using aseptic 
techniques as previously described with modifications (Rico et al., 2016; Hughes, 1962). Hair 
was clipped surrounding the 11th intercostal space, and the incision site was sanitized with iodine 
scrub and anesthetized with lidocaine HCl (5 to 10 mL; Vedco, Inc., Saint Joseph, MO) 
delivered subcutaneously. Following tissue collection, the biopsy site was stapled and sprayed 
with antiseptic. Tissue was snap-frozen in liquid nitrogen and stored at −80°C. At h 33 of 
treatment, an ITT (0.1 IU/kg of BW) was performed. Additional blood samples (8 mL) were 
collected at -10, 0, 10, 20, 40, 50, and 60 min relative to insulin infusion. Blood samples were 
processed as described above. 
Sample Analyses  
Daily dry matter contents of the mixed ration were determined by drying at 60°C until a 
static weight was observed. Mixed rations were composited and analyzed by near infrared 
reflectance spectroscopy (Cumberland Valley, Cumberland, MD; AOAC International, 1995; 
method 989.03). Serum concentrations of FFA, triacylglycerol, glucose, and total cholesterol 
were determined by enzymatic methods using commercial kits (HR Series NEFA-HR (2), L-
Type TG M, Autokit Glucose, and Cholesterol E, respectively; Wako Chemicals USA, Inc., 
Richmond, VA). All spectrophotometric measurements were conducted using a SpectraMax Plus 
384 Microplate Reader (Molecular Devices, Sunnyvale, CA). Intra- and inter-assay CV were 3.2 
and 6.8%, 2.8 and 4.1%, 3.6 and 4.6%, and 3.8 and 14.2% for FFA, triacylglycerol, glucose, and 
total cholesterol, respectively.  
 Ceramides were extracted from serum and liver using a modified Bligh and Dyer 
procedure including 12:0-Cer as an internal standard (Avanti Polar Lipids, Alabaster, AL; 
(Haughey et al., 2004; Bandaru et al., 2013). Sample extracts were injected using a LC-20A 
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HPLC (Shimadzu Corp., Kyoto, Japan) and separated by gradient elution using a C18 reverse-
phase column (ACE Technologies LTD., Aberdeen, Scotland). Samples were analyzed using an 
electrospray ionization source operating in positive ion mode that was coupled to a triple 
quadrupole mass spectrometer (5500 QTRAP, Sciex Inc. Thornhill, ON, Canada). Ion spray 
voltage was 5,500 at a temperature of 500°C and a collision gas setting of 9 psi. The declustering 
potential, entrance potential, and collision cell exit potential were set at 80, 12, and 10 V, 
respectively. Individual ceramide species were detected by multiple reaction monitoring of the 
[M+H]+ molecular ion with transition ion of 264.2 m/z. A ten-point calibration curve (0.5 to 500 
ng/mL) was constructed by plotting the area under the curve for 16:0-, 18:0-, 20:0-, 22:0-, and 
24:0-Cer (Avanti Polar Lipids). Normalized ceramide concentrations were estimated by curve 
fitting the identified ceramide species based on acyl-chain length. Spectral data quantitation was 
performed using Analyst 1.6.3 (Sciex Inc). 
Calculations and Statistical Analyses 
The area under the curve (AUC) for serum FFA (duration of treatment; AUC0-32 h) or 
glucose AUC (duration of ITT; AUC0-60 min) was calculated using the trapezoidal method as 
previously described by (Pires and Grummer, 2007b). Glucose clearance rate (%/min during 
ITT; CR40 min) = [(ln) glucose level at baseline (average of -10 and 0 min) – (ln) glucose level at 
time point 40 min)/40] × 100 (Pires and Grummer, 2007b. Data were analyzed using a mixed 
model with repeated measures including the random effect of cow and fixed effects of treatment, 
time, and their interaction in SAS (version 9.3, SAS Institute Inc., Cary, NC). When necessary, 
data were log transformed. Outliers were identified (studentized residuals > 3 or < -3) and 
removed from analysis (typically no more than 1 per variable). Parametric Pearson correlations 
were performed to determine associations between ceramide levels and insulin-stimulated 
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glucose disposal during an ITT. All results are expressed as least square means unless otherwise 
noted. Significance was determined at P ≤ 0.05 and trends toward significance were considered 
at 0.05 < P ≤ 0.10. 
Results 
Prolonged intravenous NA partially suppresses lipolysis 
 Daily dry matter intake for all cows was comparable prior to treatment (19 ± 0.55 kg/d; P 
= 0.49) and ad libitum fed cows consumed 20 ± 1.08 kg/d during treatment. Relative to feeding, 
NR increased lipolysis by h 2 (103 vs. 58 µM; P <0.05), a response that progressively increased 
for the duration of treatment (725 vs. 69 µM at h 32; P <0.001; Figure 3.1A). In response to NA 
infusion in NR cows, adipose tissue lipolysis was suppressed (P < 0.001; Figure 3.1A); however, 
long-term NA infusion was unable to prevent the gradual rise in FFA caused by feed removal. 
Collectively, adipose tissue lipolysis was suppressed 55% in cows infused NA (FFA AUC0-32 h; 
Fed, 125,131; NR, 793,641; NR + NA, 423,558 [μmol/L × 32 h]; SEM = 43,822; P <0.001). 
Coinciding with lower hepatic FFA delivery, serum concentrations of triacylglycerol were 
suppressed in NR + NA treated cows, relative to the ad libitum fed or NR treatment (h 8 or 32; P 
< 0.05; Figure 3.2A). During treatment, overall glucose homeostasis was maintained; however, 
we observed a short-term decline in circulating glucose from h 8 through 14 of NR + NA 
treatment (Figure. 3.2B). Additionally, NR in the absence or presence of NA infusion increased 
serum total cholesterol (Figure 3.2C), an effect previously observed (Sävendahl and Underwood, 
1999).Following treatment removal, serum FFA surged to 2,911 μM (P <0.01; Figure 3.1B), and 
this response was accompanied by an increase in serum triacylglycerol and glucose 
concentrations (Figure 3.2A-B). 
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Nutrient restriction increases serum and hepatic ceramide 
The ability of ceramide to inhibit insulin sensitivity may be influenced by the moiety 
(Boon et al., 2013; Raichur et al., 2014; Turpin et al., 2014). In our current study, we observed a 
greater contribution of 16:0-Cer to the total ceramide pool in non-pregnant and non-lactating 
dairy cows (Figure 3.3A and 3.4A). Consistent with previous observations in peripartal dairy 
cows experiencing negative energy balance (Rico et al., 2015), we observed a marked increase in 
circulating ceramide during nutrient restriction, relative to ad libitum feeding (Figure 3.3B-F). 
For example, NR cows exhibited increased circulating 16:0- and 24:0-Cer (75 and 78% by h 32, 
respectively; P <0.001). Moreover, re-feeding for 8 h decreased circulating 16:0- and 24:0-Cer 
by approximately 23% (P <0.001). Similar effects were observed for serum 18:0-, 20:0-, and 
22:0-Cer in NR treated cows. Although NA infusion partially suppressed lipolysis, 
administration of NA was unable to prevent the rise in circulating ceramide caused by nutrient 
restriction. Most notably, serum 22:0- and 24:0-Cer levels were enhanced by NA infusion. 
Coinciding with the surge in circulating FA, terminating NA infusion promoted a short-term 
burst in serum 18:0-Cer levels (2 h post). Although less dramatic, a similar increase post NA 
infusion was observed for serum 16:0- and 20:0-Cer concentrations.  
The ability of liver to synthesize and export ceramide has been previously established 
(Haus et al., 2009; Watt et al., 2012). Relative to ad libitum feeding, NR with or without NA 
infusion increased hepatic ceramide (56 to 116%; Figure 3.4B). Moreover, we observed a 
positive association between serum and hepatic ceramide concentrations (Figure 3.4C).   
Ceramides are Inversely Related to Insulin Tolerance 
In order to validate previous data that demonstrates impaired insulin sensitivity during 
negative energy balance (Pires and Grummer, 2006b; Oikawa and Oetzel, 2006), we assessed 
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changes in circulating glucose in response to an insulin challenge. We observed an inhibition of 
insulin-stimulated glucose disposal following NR treatment (Figure 3.5). Specifically, NR and 
NR + NA decreased CR40 min (Fed, 1.76; NR, 1.36; NR + NA, 0.88 [%/min]; SEM = 0.16; P < 
0.001) and increased glucose AUC0-60 min (Fed, 2259; NR, 2651; NR + NA, 2793 [mg/dL × 60 
min]; SEM = 169; P < 0.05) relative to ad libitum fed cows. Additionally, serum glucose 
concentrations rebounded 55% from min 40 to 60 in cows fed ad libitum, a response not 
observed for the NR or NR + NA treatment. Administration of NA was unable to restore 
systemic insulin action during nutrient restriction. To determine whether systemic insulin 
tolerance is related to circulating or hepatic ceramide supply, we performed a Pearson correlation 
analysis. We detected an inverse relationship between very long chain ceramide (i.e., serum and 
hepatic 22:0- and 24:0-Cer) levels and CR40 min (r = -0.51 to -0.42, P < 0.05; Figure 3.6A), a 
response not observed for 16:0-, 18:0-, 20:0-Cer, or FFA. We also observed a positive 
relationship between 22:0- and 24:0-Cer, and glucose AUC0-60 min (Figure 3.6B). Although 16:0-, 
18:0-, and 20:0-Cer were not related to systemic insulin action, our results support an inverse 
relationship between very long chain ceramides (22:0- and 24:0-Cer) and systemic insulin 
tolerance.  
Discussion 
Development of insulin resistance in dairy cows is mediated in part by the actions of 
growth hormone and glucocorticoids, and represents a key maternal adaptation to partition 
energy towards the mammary gland as a means to support milk production for the neonate (Bell, 
1995). Onset of insulin resistance will promote glucose sparing, increase lipolysis in adipose 
tissue, and enhance availability of FFA for oxidation or milk fat synthesis. Unfortunately, the 
modern early lactation dairy cow depends on insulin antagonism during a stage of lactation 
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characterized by decreased intake and increased energy requirements to sustain copious milk 
production. Hepatic triacylglycerol accumulation may ensue in response to sustained elevations 
in circulating FFA. These conditions can promote fatty liver disease and ketosis which can 
compromise the health, fertility, and longevity of the cow. In monogastrics, ceramide is a central 
mediator of insulin resistance, lipolysis, and hepatic lipid accumulation (Chavez and Summers, 
2012; Mei et al., 2002; Xia et al., 2015), and we have observed increased plasma ceramide levels 
in dairy cows transitioning from gestation to lactation (Rico et al., 2015). In our current study, 
we validated previous work that demonstrated impaired insulin action in response to energy 
deficit (Pires et al., 2007; Oikawa and Oetzel, 2006). More importantly, we established that 
circulating and hepatic ceramide accrual develops in nutrient-restricted dairy cows experiencing 
impaired insulin tolerance.  
Elevations in circulating FFA concentrations can cause insulin resistance in skeletal 
muscle and adipose tissue of monogastrics (Summers, 2006; Funaki, 2009). Likewise, induction 
of hyperlipidemia by nutrient restriction or tallow infusion can impair insulin sensitivity in dairy 
cows (Pires et al., 2007; Pires and Grummer, 2007a). These researchers postulate that 
establishment of FFA-induced insulin resistance in adipose tissue of peripartal dairy cows may 
support a vicious cycle in which higher FFA concentrations attenuate insulin signaling and 
sustain adipose tissue mobilization. Comparable to Pires and colleagues (Pires et al., 2007) our 
nutrient restriction protocol increased circulating FFA levels and impaired glucose clearance 
following an insulin challenge; however, intravenous NA infusion was unable to restore insulin 
sensitivity albeit lipolysis was partially suppressed and circulating triacylglycerol was 
intermittently lower. Despite reduced FFA supply, others have demonstrated impaired insulin 
sensitivity following 48 h NA administration (3 mg/h per kg of BW; delivered abomassally) in 
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cows restricted to 33% of ad libitum intake (Pires et al., 2016). Moreover, long-term niacin 
feeding in mice (15 wk dietary supplementation at 0.3% wt/wt) inhibits systemic insulin 
sensitivity and blocks insulin-inhibited lipolysis by downregulating PDE3B (Heemskerk et al., 
2014). In our investigation, the inability of 32 h NA infusion to completely suppress FFA 
mobilization may have involved a similar mechanism. In contrast to our findings and others 
(Heemskerk et al., 2014; Pires et al., 2016), earlier work (Pires et al., 2007) has revealed that NA 
administration (6 mg/h per kg of BW delivered abomassally) for a shorter duration (11 h) can 
enhance insulin-stimulated glucose clearance in feed-restricted dairy cows. Interestingly, we did 
not observe an increase in 22:0- or 24:0-Cer until h 16; therefore, the insulin-sensitizing effects 
of short-term (<16 h) NA administration at supraphysiological doses may not be accompanied by 
elevated ceramide. It is clear that the ability of NA to inhibit insulin sensitivity and lipolytic rate 
are dependent on the duration and dose of the treatment regimen; however, the mechanism of 
action remains uncertain. Therefore, we explored whether ceramide was related to energy deficit 
in the absence or presence of 34 h NA infusion.  
 Fatty acid oversupply contributes to increased hepatic de novo ceramide synthesis and 
secretion in humans and rats (Holland et al., 2007; Watt et al., 2012). In turn, lipoprotein 
ceramide mediates the development of insulin resistance in part by interfering with protein 
kinase B signaling (Boon et al., 2013; Stratford et al., 2004). Our observed elevations in NR-
induced FFA levels developed concurrently with the accumulation of ceramide in liver and 
serum, a positively correlated relationship suggesting coordinated hepatic synthesis and export. 
Moreover, following the termination of NA infusion, we observed a FFA surge-dependent 
increase in 16:0-, 18:0-, and 20:0-Cer thus indicating that rapid ceramide synthesis is possible in 
cows. This response developed in parallel with a rapid increase in circulating triacylglycerol and 
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glucose, likely caused by increased hepatic triacylglycerol export and glycerol-dependent 
gluconeogenesis (Aschenbach et al., 2010), respectively. Coinciding with improved energy 
balance, circulating ceramide was lowered by re-feeding. We have previously demonstrated a 
positive relationship between elevated circulating ceramide and FFA levels in peripartal dairy 
cows experiencing negative energy balance (Rico et al., 2015). The current study confirms an 
inverse relationship between circulating ceramide and glucose-stimulated FFA disappearance, 
thus supporting a role for ceramide as a lipolytic mediator (Rico et al., 2016). Additionally, cell-
permeable ceramide decreases PDE3B activity and inhibits insulin-induced anti-lipolysis in 3T3-
L1 adipocytes (Mei et al., 2002). Collectively, our data supports a lipolytic role for ceramide 
when cows experience increased energy demand. 
Considering that FFA serve as substrate for hepatic de novo ceramide synthesis (Merrill, 
2002), we anticipated lower hepatic and circulating ceramide concentrations in response to NA 
infusion. Contrary to our hypothesis, inhibition of lipolysis by NA was unable to suppress 
ceramide accumulation in response to feed removal. Unexpectedly, NA infusion selectively 
enhanced very long chain 22:0- and 24:0-Cer concentrations. The inability of NA to prevent NR-
induced ceramide accrual may explain why insulin-stimulated glucose disposal remained 
unchanged, relative to NR cows. Accumulation of ceramide during suppressed lipolysis suggests 
that alternative mechanisms independent of substrate supply for serine SPT and ceramide 
synthase within the de novo synthesis pathway are responsible. For instance, NA may have 
directly activated SPT. In support, Tanno and coworkers (2000) demonstrated that nicotinamide 
increases ceramide levels in human keratinocytes by enhancing SPT transcription and activity, 
and pyridoxal-5’-phosphate (vitamin B6) is a known cofactor for SPT (Wadsworth et al., 2013). 
Alternatively, NA infusion may have upregulated other ceramide generating pathways including 
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sphingomyelin hydrolysis or salvage synthesis (Hirabayashi et al., 2006). Considering that NA 
may upregulate ceramide synthesis during a catabolic state and a comparison of 14 studies 
indicated that niacin lowered FFA once (NRC, 2001), we contemplate whether supplementing 
NA at practical feeding levels during early lactation may inadvertently exacerbate insulin 
resistance.  
 The ability of ceramide to inhibit insulin sensitivity may be dependent upon the acyl 
moiety of the sphingolipid (Boon et al., 2013; Raichur et al., 2014; Turpin et al., 2014).  In our 
investigation, NR increased serum 16:0-, 18:0-, 20:0-, 22:0- and 24:0-Cer; however, the 
observed inverse relationship between ceramide and insulin sensitivity (i.e., CR40 min or AUC0-60 
min) was reserved for the 22:0 and 24:0 moiety. We have made similar observations in peripartal 
and mid-lactation dairy cows displaying enhanced total ceramide supply (Rico et al., 2015; Rico 
et al., 2016). Whereas we have previously established that 24:0-Cer is the most abundant 
ceramide in lactating dairy cows, our current study demonstrated that 16:0-Cer was the 
predominant ceramide in non-pregnant, non-lactating dairy cows. Considering that the 
contribution of very long chain ceramides to the total ceramide pool increases as cows transition 
from gestation to lactation and decline beyond peak milk yield (Rico et al., 2015; Rico et al., 
2016), relative to 16:0-Cer, our observed difference in hepatic and serum sphingolipid profiles 
likely reflect the physiological state of the animal. In support of the role of 24:0-Cer as an insulin 
antagonist, Boon and coworkers (2013) demonstrated that rodents infused with low density 
lipoproteins enriched with 24:0-Cer display impaired insulin-stimulated glucose uptake and 
protein kinase B activation. Additionally, Meikle et al. (2013) found that circulating 16:0-Cer 
elevation and the development of type 2 diabetes were not related. In contrast, others have 
proposed that skeletal muscle 16:0-Cer is a proapoptotic mediator of insulin resistance in 
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response to high-fat feeding, and 24:0-Cer confers antiapoptotic and proliferative functions 
(Raichur et al., 2014; Turpin et al., 2014). With these uncertainties recognized, the ability of 
specific ceramides to inhibit insulin action may be influenced by their compartmental origin. 
 Our work represents the first investigation to explore the relationship between controlled 
nutrient restriction, ceramide supply, and systemic insulin sensitivity in dairy cows. We 
demonstrated that hepatic and serum ceramide levels increase in response to rising circulating 
FFA levels and insulin resistance caused by nutrient restriction. Moreover, we established that 
improving the energy status of the cow can lower ceramide concentrations. In support of our 
previous findings in peripartal and mid-lactation dairy cows, we confirm that the inverse 
relationship between ceramide levels and insulin sensitivity is specific for ceramides with a 22:0 
or 24:0 moiety. We also demonstrated that long-term NA administration does not prevent the rise 
in ceramide or insulin antagonism caused by nutrient restriction. Our data suggest that ceramides 
are fundamentally involved in the adaptive metabolic changes associated with the onset of a 
catabolic state in dairy cows. 
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TABLES AND FIGURES 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3.1. Ingredients and nutrient composition (% of dry 
matter unless otherwise noted) of experimental diet when 
offered. 
Ingredient1   
    Grass hay  37.9 
    Corn grain mix2 33.1 
    Dairy pellets3 29.0 
Nutrient composition  
    Dry matter, % 85.2 
    Crude protein 19.3 
    Neutral detergent fiber 37.8 
    Acid detergent fiber 24.6 
    Starch 15.6 
    Crude fat 2.8 
    Ash 7.8 
    Net energy for lactation, Mcal/kg of dry matter 1.5 
1Ingredients were composited weekly. 
2Corn grain mix contained (as fed) 39.9% ground corn 
grain, 46.5% soybean meal, 1.7% magnesium sulfate, 0.9% 
trace mineral salt, 0.3% Sel-Plex 600 (Alltech, 
Nicholasville, KY), 0.6% Zinpro Availa-Plus (Zinpro 
Corp., Eden Prairie, MN), 8.5% Zar-Min (ZEO Inc., 
McKinney, TX), 0.4% vitamin premix ADE, and 1.2% 
vitamin premix E.  
3Dairy pellets contained (as fed) 33.1% soy hulls, 38.2% 
corn, 25.2% soy meal, 1.1% urea, 0.9% limestone, 0.4% 
calcium phosphate, 0.2% magnesium oxide, 0.5% trace 
mineral salt, and 0.4% vitamin premix ADE. 
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Figure 3.1. Intravenous infusion of nicotinic acid (NA) partially suppresses lipolysis in nutrient-
restricted (NR) dairy cows. Serum fatty acid concentrations (A) during and (B) following 
treatment in cows ad libitum fed, NR, or NR plus NA infusion (NR + NA). Intravenous infusion 
of NA was delivered at 5 mg of NA/h per kg BW. Data are represented as least squares means 
and their standard errors 
 
Figure 3.2. Circulating triacylglycerol, glucose, and total cholesterol concentrations in dairy 
cows ad libitum fed, nutrient-restricted (NR), or NR plus nicotinic acid infusion (NR + NA). 
Serum (A) triacylglycerol, (B) glucose, and (C) total cholesterol concentrations during or 
following treatment. Vertical dashed line reflects termination of saline or NA (delivered at 5 mg 
of NA/h per kg BW) infusion. Data are represented as least squares means and their standard 
errors 
Figure 3.3. Nutrient restriction increases circulating ceramide in dairy cows. Serum ceramide 
(Cer) (A) composition and (B-F) concentrations in dairy cows ad libitum fed, nutrient-restricted 
(NR), or NR plus nicotinic acid infusion (NR + NA). Composition of serum ceramides was 
evaluated at h 32. Vertical dashed line reflects termination of saline or NA (delivered at 5 mg of 
NA/h per kg BW) infusion. Data are represented as least squares means and their standard errors. 
Differing superscripts reflect statistical differences between treatments within a time point, P < 
0.05 
 
Figure 3.4. Nutrient restriction increases hepatic ceramide in dairy cows. Liver ceramide (Cer) 
(A) composition and (B) concentrations in dairy cows ad libitum fed, nutrient-restricted (NR), or 
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NR plus nicotinic acid infusion (NR + NA). (C) Random regression analysis between serum and 
hepatic total ceramide concentrations at h 32. Intravenous infusion of NA was delivered at 5 mg 
of NA/h per kg BW. Concentrations for individual ceramide moieties are represented as least 
squares means and their standard errors. Coefficient of determination (R2) represents the 
association between observed and model predicted values when accounting for the random effect 
of cow. Differing superscripts reflect statistical differences between treatments within a time 
point, P < 0.05 
 
Figure 3.5. Nutrient restriction decreases insulin sensitivity in dairy cows. Serum glucose 
response to an insulin tolerance test in dairy cows ad libitum fed, nutrient-restricted (NR), or NR 
plus nicotinic acid infusion (NR + NA). Insulin was administered at 0.1 IU/kg of BW. 
Intravenous infusion of NA was delivered at 5 mg of NA/h per kg BW. The tolerance test was 
performed at h 33 of treatment. Baseline values are represented as the average of -10 and 0 min, 
relative to start of insulin challenge. Data are represented as least squares means and their 
standard errors 
 
Figure. 3.6 Very long chain ceramides are inversely related to insulin tolerance in dairy cows. 
Relationship between ceramide (Cer) supply and insulin tolerance in dairy cows ad libitum fed, 
nutrient-restricted (NR), or NR plus nicotinic acid infusion (NR + NA). Intravenous infusion of 
NA was delivered at 5 mg of NA/h per kg BW. Measurements of insulin tolerance include 
glucose clearance rate (CR40 min; 40 min following insulin administration) and glucose area under 
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the curve (AUC0-60 min; duration of test). Data reflect serum and liver samples collected at h 32 of 
treatment. **P < 0.01, *P < 0.05, †P < 0.10 
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Chapter 4 
EFFECTS OF PREPARTUM ADIPOSITY ON PERIPARTAL SYSTEMIC AND 
LOCALIZED INSULIN SENSITIVITY IN DAIRY COWS 
Introduction 
During the gestation to lactation transition, the peripartal dairy cow exhibits a high 
glucose requirement to support the growing fetus and the increased demand for milk production. 
First, dramatic requirements for glucose by the placenta are increased 4-fold during late 
gestation, and glucose requirements can increase 7-fold at the onset of lactation to support 
mammary lactose synthesis (Bell and Bauman, 1997). Due to this dramatic increase in glucose 
requirement coupled with suppressed energy intake and amplified energy expenditure, peripartal 
dairy cows develop insulin resistance in adipose and muscle tissues as a metabolic adaptation to 
support lactation (Bell and Bauman, 1997). Because insulin is an anti-lipolytic hormone, insulin 
resistance promotes accelerated adipose tissue lipolysis and increases circulating FFA. As a 
detrimental consequence, hepatic influx of FFA can be re-esterified to form triacylglycerol 
(TAG). Excessive deposition of TAG in liver can increase ketogensis and compromise 
gluconeogenesis (Rukkwamsuk et al., 1999; Rukkwamsuk et al., 2000). If not resolved, these 
hepatic impairments can promote the development of postpartum metabolic diseases including 
fatty liver disease, ketosis, retained placenta, and mastitis (Holtenius et al., 2003; Bobe et al., 
2004; Ospina et al., 2010). Onset of a metabolic disease can comprise cow longevity and 
decrease producer profits. Understanding the mechanisms of metabolic disease will support 
development of novel approaches to improve cow health and performance during the transition 
from gestation to lactation. 
Pregnant dairy cows with enhanced adiposity during late gestation are subjected to a 
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greater loss in body weight and adiposity during the transition period. Moreover, overweight 
dairy cows experience greater lipolytic rates and increased circulating FFA concentrations 
relative to lean cows (Janovick et al., 2011; Rukkwamsuk et al., 2000). Increased hepatic lipid 
deposition, ketogenesis, systemic inflammation, and oxidative stress all contribute to increased 
disease risk in overweight dairy cows (Bobe et al., 2004; Bernabucci et al., 2005; Duffield et al., 
2009; Lacetera et al., 2005). Current recommendations are to minimize body fat gain during late 
gestation (Overton and Waldron, 2004); however, modern dairy farms manage cows within 
heterogenous groups (i.e. cows can have varying adiposity). One potential mechanism that may 
explain why overweight dairy cows experience increased body fat loss during the peripartum 
may involve reduced sensitivity to the pancreatic hormone insulin. 
In overweight monogastrics, development of insulin resistance involves a reduction in 
insulin-stimulated glucose uptake in adipocytes via mechanisms involving protein kinase B 
(AKT) inactivation (i.e. dephosphorylation; Summers et al., 1998). In turn, AKT inactivation 
suppresses translocation of glucose transporter-4 (GLUT4) to the plasma membrane in skeletal 
muscle, cardiac, and adipose tissues (Zhao and Keating, 2007). Because insulin is an anti-
lipolytic hormone, insulin resistance can promote adipose tissue lipolysis by activating hormone-
sensitive lipase (Sumner and McNamara, 2007). In the ruminant dairy cow, early evidence has 
demonstrated the inactivation of AKT postpartum (Zachut et al., 2013); however, the ability of 
adiposity to influence adipose tissue AKT phosphorylation status in response to insulin is 
uncertain.  
Development of adipose tissue insulin resistance offers a potential explanation for why 
overweight cows exhibit a higher concentration of circulating FFA and a greater tendency to 
develop metabolic disease. By employing several measurements of insulin sensitivity, our 
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objective was to examine changes in systemic and localized insulin sensitivity in lean and 
overweight peripartal dairy cows. Specifically, we utilized the hyperinsulinemic-euglycemic 
(HEC; Kim, 2009) clamp method to measure glucose infusion rate in cows experiencing 
sustained elevations in blood insulin concentrations. We also measured phosphorylation status of 
AKT in subcutaneous adipose tissue (SubqAT), as well as circulating levels of several related 
markers including insulin, FFA, and glucose. We hypothesized that enhanced adiposity in 
periparturient dairy cows is associated with reduced glucose infusion during the HEC, increased 
fat loss, and lower localized insulin sensitivity. 
Materials and Methods 
Experimental Design 
Experimental procedures were approved by the West Virginia University Institutional 
Animal Care and Use Committee (Morgantown). The experiment was completed at Dovan 
Farms, WVU Agricultural Research and Education Partner, and a 700-Holstein cow commercial 
dairy farm (located in Berlin, PA). Twenty-five pregnant, multiparous (3.6  1.60 lactations) 
Holstein dairy cows were enrolled into the study 28 d before expected parturition. Five cows 
were removed from the study and replaced for health reasons (2 displaced abomasum, 1 severe 
mastitis, and 2 complete cessation of eating). Cows were randomly selected and immediately 
allocated into one of two treatment groups per their prepartum adiposity, using a 1 to 5 body 
condition score (BCS; overweight (i.e. overconditioned), 3.9  0.30 BCS or lean, 3.0  0.16 
BCS; Wildman et al., 1982) and back fat thickness (BFT; overweight, 15.2  0.86 mm or lean, 
10.2  0.80 mm). Cows had free access to water while fed twice daily (0700 h and 1700 h) for ad 
libitum intake to meet or exceed nutrient recommendations during pregnancy and lactation. 
Cows were milked twice daily (0600 and 2030 h) using a portable milking unit from parturition 
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through d 12, then milked three times per day with the main herd. Body weight (BW) was 
recorded weekly. Four trained examiners independently recorded BCS for individual cows. Body 
condition score data for each cow was averaged weekly from d -28 to d 28 relative to parturition. 
Back fat thickness was measured weekly using an ultrasound according to the methods of 
Schröder and Staufenbiel (2006).  
Sampling Collection 
Prior to morning feeding, blood samples (10 mL) were collected via coccygeal 
venipuncture weekly starting at enrollment until d -7, then daily until to d 8, followed by d 10, 
12, 14, 21, and 28, relative to calving. Blood samples were placed on ice for 30 min until 
centrifugation at 3,400 × g for 10 min. Plasma was then removed after centrifugation and snap-
frozen in liquid nitrogen. Samples were then stored for analysis at -20ºC for no longer than two 
weeks then moved to -80ºC for long-term storage. Total mixed ration (TMR) samples were 
collected once every two weeks, and composited monthly for analysis. Milk samples were 
collected at each milking on d 1, 3, 5, 7, 10, 12, 14, 21, and 28 relative to parturition. Samples 
were kept at 4ºC and preserved using Bronopol tablets (D&F Control Systems, San Ramon, CA) 
for milk composition analysis.  
Liver and adipose biopsies were performed on d -12 and 10 relative to calving. For liver 
biopsies, the incision site was located with the 11th intercostal space by making an incision 0.5-
cm through the skin. Using a custom trocar, 1 g of liver tissue was collected (Hughes, 1962) and 
snap-frozen in liquid nitrogen. Within 48 h, biopsy samples were removed from liquid nitrogen 
and stored at -80°C. To evaluate adipose tissue AKT activation (i.e. phosphorylation), 50-100 
mg of adipose tissue was removed from the cow and incubated in DMEM medium containing 
1% BSA, 1M acetate, and 5 mM glucose for 10 min at 39˚C to reflect physiological conditions. 
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The tissue was then spiked with 1 mM insulin. After incubation at 39˚C for 15 min, the tissue 
was removed from the solution and snap-frozen in liquid nitrogen. Additionally, an adipose 
explant was harvested, placed in a cassette, and stored in formalin for histology analyses. After 
tissue collection, biopsy sites were cleaned with hydrogen peroxide, stapled, and sprayed with 
antiseptic (Blu-Kote; H.W. Naylor Co. INC; Morris, NY).  
The HEC procedure was performed at d -10 and 12 relative to calving. Three jugular 
catheters (Micro-Renathane Implantation tubing, 2.03 mm outside diameter × 1.02 mm inside 
diameter; Braintree Scientific Inc., Braintree, MA; Schoenberg et al., 2012) were inserted the 
evening prior to the HEC and flushed with heparinized saline every 7 h to maintain patency. One 
catheter was used for blood sampling, and the other, in the opposite jugular vein, was used for 
insulin and glucose infusion. Infusion lines were attached to the same catheter using an anti-y 
port (Millpledge North America Inc, CA). The insulin solution was prepared using bovine 
insulin stock solution (1 mg/mL; Humulin R; Lilly and Co., Indianapolis, IN), sterile saline, and 
harvested plasma for insulin infusates (2.5% of total solution volume; DeFronzo et al., 1979). In 
order to calculate insulin dose, body weight was recorded once daily for two days before the 
HEC and averaged. Feed was removed two hours prior to the start of the HEC which occurred 
prior to the morning feeding. An insulin priming dose was introduced intravenously to raise 
blood insulin levels (DeFronzo et al., 1979). Subsequently, infusion lines were attached and 
insulin (1 µg/kg of BW, 27 IU/mg, at 9.0 mL/h) was administered using a syringe pump (New 
Era Pump Systems Inc., Farmingdale, NY). Concurrently, glucose (50% dextrose solution) was 
infused using a Macro XL Plum Pump (Abbott Laboratories, North Chicago, IL) at 9 mL per h 
until insulin noticeably dropped blood glucose levels measured by a hand-held glucometer 
(Precision Xtra, Abbott Diabetes Care Inc., Alameda, CA). Glucose infusion rate was adjusted 
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variably to reach and maintain a steady state euglycemia for 30 min minimum. The target steady 
state range was considered to be the average of five basal glucose concentrations immediately 
prior to HEC. The steady state range extended  10% beyond this basal average. The resulting 
steady-state glucose infusion needed to maintain euglycemia was a reflection of insulin action. 
Sample Analyses  
Total mixed ration dry matter (DM) contents were determined by drying at 60ºC until a 
static weight was achieved. Additional TMR samples were submitted to a commercial laboratory 
for nutrient composition by near-infrared spectroscopy (Cumberland Valley, Cumberland, MD; 
AOAC International, 1995; method 989.03). Milk samples were individually sampled and 
analyzed for true protein, lactose, and fat concentrations within 1 wk of collection. Samples were 
also analyzed for MUN using mid-infrared spectroscopy and SCC by flow cytometry (Dairy 
One, Hagerstown, MD; AOAC, 1990; method 972.160).  
Plasma glucose, FFA, and BHBA concentrations were measured using enzymatic kits 
(Autokit Glucose, HR Series NEFA-HR (2), Autokit 3-HB, respectively; Wako Chemicals USA, 
Inc., Richmond, VA). Serum insulin concentrations were determined using ELISA (Mercodia 
Bovine Insulin ELISA; Mercodia AB, Uppsala, Sweden). All spectrophotometric measurements 
were conducted using a SpectraMax Plus 384 Microplate Reader (Molecular Devices, 
Sunnyvale, CA). Intra- and inter-assay CV were 4.0 and 4.2%, 3.1 and 11.9%, 2.4 and 9.1%, and 
4.8 and 16.5% for glucose, FFA, BHBA, and insulin, respectively. Liver lipid was extracted and 
quantified using previously described methods (Hara and Radin, 1978; Piepenbrink and Overton, 
2003b).  
For analysis of AKT phosphorylation, basal and insulin-stimulated SubqAT samples (~50 
mg of tissue) were pulverized in a bead blender, and ice-cold lysis buffer (20 mM tris base, 50 
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mM NaCl, 50 mM NaF, 5 mM Na4O7P2, 250 mM sucrose, 1% (v/v) Triton X-100, 500 mM 
dithiothreitol, and protease inhibitor; 14 μl/mg of tissue) was added. Samples were centrifuged at 
4˚C at 14,000 × g for 15 min. Tissue lysates were stored at -80˚C until further analysis. Loading 
dye with denaturing agent was added to samples which were subsequently heated to 70˚C for 10 
min and then cooled on ice. Samples were loaded on the gel at 50 μg of protein per lane. The gel 
was run at 150 V for 1.5 h. The protein was transferred to a nitrocellulose membrane. The 
transfer tank was submerged in ice at 120 V for 2h. The membrane was blocked for 30 min 
under agitation using a 5% TBST in non-fat dry milk solution. The membranes were rinsed with 
TBST and incubated overnight with primary antibodies, phosphorylated AKT (pAKT; Ser473; 
1:1000) or total AKT (tAKT; 1:1000; Cell signaling, Technology, Danvers, MA) under agitation. 
Membranes were washed with 1X TBST and incubated with secondary antibody (1:2000; 
Alexafluor 680, Life Technologies Corporation, Eugene, OR) for 60 min with agitation at room 
temperature. After incubation, the membrane was washed with TBST for 5 min, repeatedly 
washed 3X. Blots were scanned using a NIR fluoresce system (Odyssey imager, LICOR 
Biosciences, Lincoln, NE) and densitometry was performed using Odyssey Infrared Imaging 
software (V. 3.0.29). 
The adipose tissue stored in formalin were processed by a trained pathologist using a 
tissue processor. The tissue was embedded using molten paraffin and allowed to harden on a 
cryo console. The tissue was then removed from the mold and placed in the refrigerator until it 
was sliced. Before staining, the slides were deparaffinized using xylene, and the nucleus and 
cytoplasm were stained with hematoxylin and eosin, respectively. Once the slides were fixed, 
adipocyte volume and counts were recorded using Image J software (NIH Image J; NIH, 
Bethesda, MD). 
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Calculations and Statistical Analyses 
Plasma and serum data were analyzed using a mixed model with repeated measures in 
SAS (V 9.3, SAS Institute Inc., Cary, NC). The model included the random effect of cow, and 
the fixed effects of treatment, day relative to parturition, and their interaction. The SLICE effect 
was utilized to analyze treatment differences by time. Studentized residuals < -3 or >3 were 
considered outliers and were removed from the dataset (typically no more than 2 per 
analysis).  When necessary, data were transformed and presented in the original scale. Parametric 
Pearson correlations were performed to determine associations between measures of insulin 
sensitivity (GIR, SS glucose, pAKT) and adiposity, basal FFA, glucose, and BHBA. The 
significance level was set at P ≤ 0.05, and trends toward significance were considered at 
0.05 < P ≤ 0.10. The insulin sensitivity index was calculated as follows: SIClamp = glucose 
infusion rate/ [(steady state glucose) × (steady state insulin – basal insulin)], (Muniyappa et al., 
2007).  
Results 
 Body condition scores at enrollment were significantly different between lean (3.0  0.16) 
and overweight (3.9  0.30) cows (P < 0.001). For all cows, adiposity declined during the transition 
from gestation to lactation (Figure 4.1), more so for cows with enhanced prepartum adiposity. 
Specifically, overweight cows experienced a 29% decrease in BCS (P <0.001; Figure 4.1A and 
4.1D), a 15% decrease in BW (P <0.001; Figure 4.1B and 4.1E), and a 37% decrease in BFT 
(Figure 4.1C and 4.F), relative to lean cows. Moreover, prepartum adipocyte volume was 
significantly augmented for overweight cows (Figure 4.2A; P < 0.01), a response that was negated 
by the transition from gestation to lactation. Although adipocyte number was not affected by 
gestational adiposity, adipocyte volume decreased 14% from pre- to postpartum (Figure 4.2; P < 
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0.01). Changes in adiposity loss were not due to changes in DMI, a response variable that declined 
as parturition approached but was comparable for lean and overweight dairy cows (Figure 4.3).  
Overweight cows tended to exhibit increased milk yields compared to lean cows (Figure 
4.4A; P = 0.08), which may be attributed to more severe negative energy balance and thus 
weight loss. Notably, milk yield declined briefly following the HEC procedure on d 12 
postpartum (Figure 4.4A; P < 0.01), a response that can be attributed to the reduction in intake 
observed the previous day (Figure 4.3). Regarding milk composition, milk fat yield and 
percentage was greater in cows with enhanced prepartum adiposity (Figure 4.4B-C; P < 0.05). 
Milk protein yield (Figure 4.4D; P = 0.11) and milk protein percentage were not affected by 
adiposity, but milk protein percentage decreased over time as milk yield increased (Figure 4.4E; 
P < 0.001). Milk lactose yield and content increased with time (P < 0.001; Figure 4.4F and 
4.4G), a variable that was not influenced by adiposity. 
 Prepartum adiposity did not modify plasma glucose concentrations (Figure 4.5A); 
however circulating glucose concentrations spiked by 20% at parturition (P < 0.001).  
Overweight cows displayed elevated circulating FFA concentrations throughout the peripartum 
(Figure 4.5B and Table 4.2; P < 0.001). Noticeably, overweight cows experienced a 74% 
increase in FFA concentration at parturition relative to lean cows. The increase in circulating 
FFA postpartum was accompanied by a reduction in circulating insulin (Table 4.2; P < 0.05). As 
expected, elevated postpartum plasma FFA levels were accompanied by increased liver lipid 
accumulation in overweight cows (Figure 4.6A; P < 0.05). Furthermore, hepatic lipid deposition 
developed concomitantly with increased circulating BHBA levels (Figure 4.6B; P < 0.001), more 
so in overweight cows. 
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Measurements of systemic insulin sensitivity following the HEC are described within 
Table 4.2. At the time of prepartum and postpartum HEC, BCS was significantly higher for 
overweight cows compared to lean cows (P < 0.001). Prepartum, basal serum FFA and glucose 
concentrations were comparable; however, postpartum basal serum FFA levels were moderately 
elevated in overweight cows (P < 0.05), while plasma glucose remained stable. Additionally, 
circulating basal insulin levels were not affected by adiposity (P = 0.13). During the HEC, steady 
state (SS) insulin increased 332%, relative to basal insulin levels; a response that was not 
modified by adiposity group. Demonstrating the effectiveness of the HEC, euglycemia was 
maintained as demonstrated by SS glucose levels that were comparable to basal glucose levels. 
Additionally, the HEC lowered circulating FFA levels during SS. As a direct measure of insulin 
sensitivity, peripartal glucose infusion rate (GIR) was not affected by adiposity, albeit GIR 
increased 63% postpartum (P < 0.01). Accounting for changes in glucose and insulin, SIClamp 
values were lower for overweight cows postpartum (P < 0.05). 
Under normal physiological conditions protein kinase B is phosphorylated in response to 
insulin and causes GLUT4 to translocate to the plasma membrane to support glucose uptake 
(Summers et al., 1998). In the present study, the ratio of basal phosphorylated AKT to total AKT 
(pAKT/tAKT) in SubqAT was not affected by adiposity; however, SubqAT pAKT/tAKT 
decreased from pre- to postpartum (Figure 4.7A; P < 0.05). Similarly, adiposity did not modify 
pAKT/tAKT in insulin-stimulated SubqAT, but pAKT/tAKT decreased during the transition 
from gestation to lactation (Figure 4.7B; P < 0.01).  
Pearson correlation analysis was performed between BCS at the time of HEC (BCSHEC), 
BCS loss, pAKT/tAKT in basal and insulin-stimulated SubqAT, and HEC variables (basal and 
SS FFA, glucose, insulin; GIR; and SIClamp) both pre- and postpartum. Prepartum, BCSHEC 
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tended to be positively correlated with basal insulin concentration (r = 0.38; P = 0.09). 
Postpartum, we detected a positive correlation between BCSHEC and basal FFA (r = 0.39; P = 
0.05), basal insulin (r = 0.51; P < 0.05), and SS insulin (r = 0.43; P < 0.05), and a tendency for a 
positive correlation between BCSHEC and SS FFA (r = 0.39; P < 0.09). We also detected a 
negative correlation between BCS loss and SIClamp postpartum (r = -0.48; P < 0.05). We detected 
a negative association between prepartum basal SubqAT pAKT/tAKT and basal glucose 
concentration (r = -0.50; P < 0.05), However, we were not able to detect any other correlations 
between SubqAT pAKT/tAKT and HEC variables. 
Discussion 
Periparturient dairy cows experience a dynamic shift in adipose tissue metabolism from 
energy storage at the end of lactation to rapid mobilization to meet the energy demands 
associated with lactation (McNamara, 1991). During the transition from gestation to lactation, 
adipocytes become insulin resistant, and basal and catecholamine-stimulated lipolysis is 
enhanced, representing a homeorhetic adaptation to partition nutrients to the mammary gland and 
support milk production (Bauman and Currie, 1980; McNamara, 1991; Vernon, 2005). Since 
overweight cows display greater FFA mobilization, we hypothesized that overweight cows 
would experience a greater reduction in systemic and adipose tissue specific insulin sensitivity 
compared to lean cows during the peripartal period.  
Reaffirming the adequacy of our experimental design, overweight cows had greater 
prepartum BCS, BW, BFT, and adipocyte volume relative to their lean counterparts. While all 
cows experienced a significant reduction in adiposity measurements during the experimental 
period, overweight cows experienced a greater reduction relative to lean cows. All cows 
exhibited a surge in plasma FFA and BHBA at calving, followed by sustained elevations for 
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these metabolites postpartum, leading to higher hepatic lipid deposition relative to prepartum. 
Further supporting the observation of greater adipose tissue mobilization, overweight cows had 
higher circulating FFA levels, exhibited greater hepatic lipid deposition, and as a consequence 
displayed elevated plasma BHBA levels compared to their lean counterparts. Consistent with 
these observations, DeKoster and coworkers (2016) found that adipocyte size increases with 
increasing BCS and that larger fat cells have higher basal and isoproterenol (an isopropyl analog 
of epinephrine)-stimulated lipolytic activity. Moreover, changes in peripartal overnutrition may 
mediate these responses. For example, Mann and coworkers (2016) overfed cows energy (150% 
of predicted requirements) during the dry period and these cows displayed increased circulating 
FFA and BHBA concentrations postpartum whereas cows that were fed a diet to meet 
requirements benefited from improved metabolic health. However, Mann et al. (2016) did not 
observe changes in adipose tissue hormone sensitive lipase activity in response to overfeeding, 
indicating that the rate of lipolysis was similar between cows fed at different energy levels.  
As expected, dry matter intake declined around parturition. This can partially be 
explained by reduced rumen volume due to a growing fetus. Additionally, ketones can suppress 
appetite (Allen et al., 2014), and potentially the characteristic reduction in leptin around 
parturition may inactivate orexigenic hypothalamic signals (Liefers et al., 2003). While we did 
not observe a difference in DMI between lean and overweight cows, the effects of adiposity on 
DMI in previous studies are inconclusive (Kokkonen et al., 2005; Samii et al., 2015). Both lean 
and overweight cows increased milk production over time, which can be explained by a 
reduction in insulin and insulin sensitivity postpartum to facilitate glucose sparing for lactose 
production. In the present study, overweight cows tended to produce more milk than lean cows. 
This increase in milk yield for overweight cows is in contrast to the work of Zachut and 
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coworkers (2013), who observed that cows experiencing high weight loss produced less milk 
than cows experiencing low weight loss. However, it is important to note that animals diagnosed 
with a clinical metabolic disease will have a reduction in milk yield (Deluyker et al., 1991; Lean 
et al., 1994), and animals that are more insulin resistant will produce more milk (De Koster and 
Opsomer, 2013). Therefore, a possible explanation for the increased milk yield in our overweight 
cows is that they were not diagnosed with a metabolic disease. In support, other researchers have 
reported elevated milk yield in cows with greater BCS when they were metabolically healthy 
(Roche et al., 2006; Roche et al., 2007; McCarthy et al., 2007). Furthermore, the increased milk 
yield in overweight animals suggests they were experiencing greater negative energy balance, 
insulin resistance, and partitioning of nutrients to the mammary gland. In support of greater 
nutrient partitioning, overweight cows displayed increased milk fat concentrations and 
percentage due to elevated lipolysis and FFA availability. Lactose concentration increased over 
time with increasing milk production since lactose is the major osmotic regulator of milk 
volume.  
Changes in circulating FFA are often related to pancreatic insulin secretion (Crespin et 
al., 1969; Crespin et al., 1973). In monogastrics, insulin resistance is characterized by elevated 
levels of blood insulin (Reaven et al., 1988; Thévenod, 2008), whereas ruminants experience 
insulin resistance during a characteristic decline in insulin concentration postpartum (Bauman 
and Currie, 1980; Bell, 1995; Bell and Bauman, 1997). We observed that independent of 
adiposity, basal insulin concentrations decreased postpartum, which is supported by Zachut and 
coworkers (2013). This reduction in insulin can contribute to the glucose sparing effect 
characteristic of early lactation. This is demonstrated by the reduction in circulating glucose 
observed postpartum, a response that can be exacerbated by reduced hepatic glucose synthesis 
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due to lipid deposition (Piepenbrink and Overton, 2003b). Whereas we observed no effect of 
adiposity on insulin concentration pre- or postpartum, Rico and colleagues (2015), observed that 
overweight cows had higher circulating insulin concentrations than lean cows both pre- and 
postpartum; however, their investigation did not include an evaluation of DMI which may 
explain their insulin response (Drackley et al., 2005). Moreover, we found that adiposity did not 
affect plasma glucose concentrations prepartum. Overfeeding dietary energy has been 
demonstrated to increase circulating glucose during late gestation (Mann et al., 2016); however, 
in our study DMI was comparable for lean and overweight cows; therefore, propionate supply 
for hepatic gluconeogenesis was likely comparable.  
We have previously observed that overweight cows have impaired systemic insulin 
sensitivity during the transition from gestation to lactation as estimated using the revised 
quantitative insulin sensitivity check index (RQUICKI; Holtenius and Holtenius, 2007; Rico et 
al., 2015). However, we now contemplate the validity of using estimates of insulin sensitivity 
since they rely heavily on FFA concentrations and have been demonstrated not to be correlated 
with direct measurements of insulin sensitivity in periparturient dairy cows (Schoenberg et al., 
2012; Samii et al., 2015). Additionally, overconditioned ewes experienced a reduction on insulin 
sensitivity as indicated by an HEC (Bergman et al., 1989). Therefore, we decided to use the gold 
standard HEC approach for measuring insulin sensitivity and also determine if changes in 
systemic insulin sensitivity are due to local changes in adipose tissue.  
From the pre- to postpartum HEC, both groups experienced an increase in basal and SS 
FFA. Furthermore, SS insulin was reduced. Other than elevated basal FFA and numerically 
higher basal insulin postpartum, overweight cows displayed no differences in HEC blood 
metabolite parameters. While GIR increased for both groups from pre- to postpartum due to 
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increase glucose requirements for milk synthesis, we did not detect an effect of adiposity on 
GIR. However, when accounting for changes in glucose and insulin, we demonstrated decreased 
systemic insulin sensitivity in overweight cows postpartum using the SIClamp. We have previously 
observed no effect of adiposity in response to an ITT or GTT (Samii et al., 2015). However, 
Samii et al. (2015) did not measure circulating insulin during the tolerance tests and therefore 
insulin maybe have been higher in overweight cows even though plasma glucose concentrations 
remained stable. Furthermore, the doses of insulin and glucose given previously were 
supraphysiological (insulin: 0.1 IU/kg BW; glucose: 0.3g/kg BW) and therefore may not be 
practical for determining insulin sensitivity (Samii et al., 2015). Lastly, these tests were given in 
the afternoon following morning feeding, whereas the HEC in the present study was performed 
before feeding. In support of our findings, we have also observed that glucose-stimulated 
reduction of plasma fatty acids following a GTT decreased from pre- to postpartum and was 
lower for overweight cows (Samii et al., 2015; Rico et al., 2017). When considering 
simultaneous changes in glucose and insulin, our work suggests that overweight cows experience 
a reduction in systemic insulin sensitivity compared to lean cows.  
In the present study the ratio of pAKT/tAKT decreased from pre- to postpartum as 
expected. However, we were unable to detect an effect of adiposity or adiposity loss on 
pAKT/tAKT pre- and postpartum. This result is consistent with the results of Mann and 
coworkers (2016) in cows previously fed a high plane of nutrition during the dry period; 
however, we note that their cows had markedly lower BFT measurements than the cows in our 
study, and the difference between their treatment groups was not as dramatic. It has been 
hypothesized that the reason overweight cows exhibit higher concentrations of FFA is either due 
to specific changes in the lipolytic activity of adipose tissue or due to the greater amount of fat to 
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mobilize (Rukkwamsuk et al., 1998; Herdt, 2000). While we did not observe any changes in 
adipose tissue insulin signaling in overweight cows via AKT, Zachut and coworkers (2013) 
measured AKT phosphorylation in SubqAT before and after a GTT and found decreased 
pAKT/tAKT only in the cows who experienced high weight loss, suggesting adipose tissue-
specific insulin resistance in these cows. DeKoster and coworkers (2016) observed that larger 
adipocytes tend to be more resistant to the maximal antilipolytic effect of insulin. Therefore, 
perhaps insulin signaling in adipose tissue could be affected via alternative mechanisms besides 
AKT phosphorylation. For example, Choi and coworkers (2010) found that insulin regulates 
adipocyte lipolysis through an AKT-independent, PI3K-dependent signaling pathway, which 
leads to selective PKA phosphorylation of perilipin, while HSL activation remains AKT-
dependent. We also suggest that adipose tissue depots in distinct locations may respond 
differently to changes during the periparturient period. For example, Locher and colleagues 
(2011) suggest that retroperitoneal adipose tissue is more sensitive to periparturient changes in 
HSL phosphorylation than SubqAT. In contrast to this hypothesis, De Koster and coworkers 
(2016) found that independently of the location of the adipose tissue (Subq or omental), lipolytic 
activity increased with adipocyte volume. Lastly, insulin-stimulated phosphorylation of AKT is 
impaired in humans with insulin resistance and type 2 diabetes (Karlsson et al., 2005). We note 
that it is possible that changes in systemic insulin sensitivity could be due to insulin antagonism 
in skeletal muscle, rather than in adipose tissue of overweight dairy cows. Further research is 
needed to investigate this possibility in dairy cows.   
Conclusion 
 In the present study all cows experienced elevated FFA, liver lipid, and BHBA 
concentrations during the transition from gestation to lactation, and these responses were more 
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severe for overweight cows. While we did observe a decrease in SubqAT pAKT/tAKT indicating 
reduced adipose-tissue specific insulin signaling postpartum, the elevations in FFA, liver lipid, 
and BHBA in overweight cows were not due to changes in SubqAT AKT phosphorylation. More 
severe systemic insulin resistance developed in overweight cows postpartum when accounting 
for changes in insulin and glucose. This result is potentially due to numerically higher insulin 
concentrations in overweight cows with no change in glucose concentrations. Further research is 
needed to determine if overweight cows mobilize a greater amount of adipose tissue due to 
specific changes in adipose tissue signaling leading to greater lipolysis or simply because of a 
greater amount of adipose tissue mass. Additionally, future work should investigate insulin 
sensitivity changes in different adipose depots, as well as skeletal muscle, and investigate AKT-
independent pathways. 
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TABLES AND FIGURES 
Table 4.1. Feed ingredients and composition (% of DM unless otherwise noted) for all cows 
from 28 d before to 28 d after parturition. 
 Diet 
Item d -28 to parturition Parturition to d 28 
Ingredient   
Corn silage 29.0 33.2 
Mixed grass haylage 21.7 8.61 
Mixed grass hay 25.0 1.95 
Dry ground corn 2.72 20.8 
Prepartum mix1 12.8 - 
Lactation mix A2 - 17.8 
Aminoplus 5.82 5.72 
Cottonseed with lint - 4.35 
Sugar cane syrup - 3.40 
Lactation mix B3 - 4.19 
Close-up supplement4 3.01 - 
Nutrient composition   
DM, % 51.3 51.7 
NDF 47.9 31.1 
ADF 30.5 19.8 
CP 13.4 15.5 
Crude Fat 3.30 4.80 
Ash 8.30 7.90 
NEL, Mcal/kg DM 1.43 1.70 
1Mix contained 27% commercial dry cow mix with Animate (Phibro Animal Health Corp., Teaneck, NJ), 
17.3% ground corn, 17.3% crimped oats, 13% corn distillers, 12.9% soybean meal, 4.3% calcium 
carbonate, 4.3% calcium sulfate, 2.6% Omnigen AF (Phibro Animal Health Corp.), 1.1 Monocalcium 
phosphate, and < 1% of each of the following: Sel-plex 600 (Alltech Biotechnology, Nicholasville, KY) 
and vitamin E.  
 
2Mix contained 33.6% citrus pulp, 19% soybean meal. 15.6% canola meal, 14% soybean hulls, 4.5% 
calcium carbonate, 4.5% sodium bicarbonate, 2.8% urea, 2.7% fat, 2.4% sodium chloride, and <1% from 
each of the following: Monocalcium phosphate, biotin, and Rumensin 90 (Elanco Animal Health, 
Greenfield, IN).  
 
3Mix contained 43.6% Fermenten (Church and Dwight Co., Princeton, NJ), 21.8% calcium carbonate, 
10.8% soybean hulls, 7.8% Mintrex blend (Novus International Inc., St. Charles, MO), 5.2% blood meal, 
3.5% mag- nesium oxide, 2.6% Celmanax (Vi-COR, Mason City, IA), 2.6% Omnigen (Phibro Animal 
Health Corp.), and <1% of each of the following: vitamin E, selenium selenite, and selenium yeast 600.  
 
4Mix contained 74.5% ground oats, 15.3% commercial amino acid, 8% Reashure (Balchem Encapsulates, 
Slate Hill, NY), and <1% of each of the following: vitamin E and Niashure (Balchem Corporation, New 
Hampton.   
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Table 4.2. Metabolic responses to hyperinsulinemic-euglycemic clamp. 
 BCS1  P-value 
 Prepartum  Postpartum  Main Effects3 
Item Lean Over SEM2  Lean Over SEM  BCS Stage 
BCS × 
Stage 
BCS at time of HEC 2.97 3.92* 0.05  2.58 3.33* 0.05  <0.01 <0.01 0.10 
Basal FFA (mmol/L) 715 784 91.70  1020 1300* 85.4  0.10 <0.01 0.14 
SS FFA (mmol/L) 182 220 28.14  319 437 56.9  0.11 <0.01 0.65 
Basal Glucose (mg/dL) 63.4 60.3 3.84  57.9 61.3 3.65  0.98 0.53 0.37 
SS Glucose (mg/dL) 66.2 65.2 3.70  63.4 69.4 3.88  0.54 0.84 0.33 
Basal Insulin (µU/mL) 7.72 11.1 2.13  3.71 8.4 2.09  0.13 0.04 0.65 
SS Insulin (µU/mL) 42.8 41.3 3.02  22.6 28.0 2.94  0.52 <0.01 0.25 
GIR4 (mol/min/kg)  11.8 11.9 1.43  21.4 17.4* 1.42  0.18 <0.01 0.16 
SIclamp
5  0.15 0.17 0.03  0.51 0.26* 0.03  <0.01 <0.01 <0.01 
   1Treatment were overweight cows during prepartum and postpartum. 
   2SEM is the average between lean and overweight standard errors. 
   3Main effects across prepartum and postpartum, d -10 and +12 respectively, during treatment. Data are presented as LS Means ± SEM. *P < 0.05, 
Lean vs. Overweight. 
   4Glucose infusion rate.  
 5Insulin sensitivity index = (GIR / [SS Glucose × (SS Insulin – Basal Insulin)
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Figure 4.1. Effects of adiposity on body fat mass. (A) BCS, (B) BW, and (C) BFT records during 
the transition from gestation to lactation; (D) changes in BCS, (E) BW, and (F) between d -21 
and 28 d relative to parturition. Data are presented as least square means and their standard 
errors. *P < 0.001. 
Figure 4.2. Effects of adiposity on adipocyte histology. (A) Adipocyte volume and (B) adipocyte 
count per 743.8 × 557.9 µm reading frame measured in SubqAT at 12 d before and 10 d after 
parturition. Data are presented as least square means and their standard errors. *P < 0.001. 
Figure 4.3. Effects of adiposity on dry matter intake (DMI). DMI between d -21 and d 28 relative 
to parturition. Data are presented as least square means and their standard errors. 
Figure 4.4. Effects of adiposity on milk production and composition. (A) Milk yield from d 0 
until d 28 relative to parturition; (B) fat yield, (C) fat percent, (D) protein yield, (E) protein 
percent, (F) lactose yield, and (E) lactose percent in milk on d 1, 3, 5, 7, 10, 12, 14, 21, and 28 
relative to parturition. Data are presented as least square means and their standard errors. 
Figure 4.5. Effects of adiposity on blood metabolites. (A) plasma glucose and (B) free fatty acid 
(FFA) concentrations from d -21 to d 28 relative to parturition. Data are presented as least square 
means and their standard errors. 
Figure 4.6. Effects of adiposity on (A) liver lipid percentage and (B) plasma BHBA 
concentrations from d -21 to d 28 relative to parturition. Data are presented as least square means 
and their standard errors. 
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Figure 4.7. Effects of adiposity on localized insulin signaling. Ratio of phosphorylated to total 
protein kinase B (AKT) in (A) basal and (B) insulin-stimulated subcutaneous adipose tissue 
explants (SubqAT) on d -12 and d 10 relative to parturition. Data are presented as least square 
means and their standard errors. 
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Figure 4.1 
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Figure 4.2 
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Figure 4.3 
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Figure 4.4 
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Fig. 4.5 
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Fig. 4.6 
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Figure 4.7 
  
 
 
69 
 
Chapter 5 
GENERAL CONCLUSIONS 
 With the experiments presented in this thesis, we have evaluated the relationship between 
free fatty acid supply, ceramide, and insulin sensitivity in dairy cows. We used a mass 
spectrometry to quantify ceramide in serum and in the liver. We also determined that nutrient 
restriction causes elevations in FFA, circulating ceramide, and hepatic ceramide and that long 
chain ceramide is negatively associated with insulin sensitivity. Additionally, we used the gold-
standard approach for directly measuring systemic insulin sensitivity in lean and overweight 
cows and found that prepartum adiposity reduced systemic insulin sensitivity when taking into 
account basal glucose and insulin concentrations. Contrary to our original hypothesis prepartum 
adiposity did not impair localized insulin sensitivity via AKT-dependent mechanisms. Overall, 
we show that elevations in FFA either through nutrient restriction or due to enhanced prepartum 
adiposity and lipolysis can impair systemic insulin sensitivity. Our results suggest that ceramide 
accrual represents a metabolic adaptation to nutrient restriction and impaired insulin action in 
dairy cows.  
 Future research should determine the compartmental origin of circulating ceramide, 
demonstrate that ceramides are a causal inhibitor of insulin action, develop novel nutritional 
interventions to prevent ceramide accumulation, and determine the efficacy of using 24:0-
ceramide as a biomarker for metabolic disease. Coming work should also consider whether the 
cause of elevated circulating FFA in overweight cows is due to specific changes in signaling in 
distinct adipose tissue depots or due to greater fat mass to mobilize. Collectively, these 
approaches have the potential to delineate the coordinated shift in metabolism that occurs during 
the periparturient period in order to improve dairy cow health.  
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